JP5711120B2 - Method for carbonylation of ethylenically unsaturated compounds, novel carbonylated ligands and catalyst systems incorporating such ligands - Google Patents

Description

  The present invention relates to carbonylation processes for selected ethylenically unsaturated compounds, in particular their alkoxy and hydroxy-carbonylation processes, novel bidentate ligands and novel catalyst systems incorporating such ligands.

  Alcohol or water, and Group 6, 8, 9 or 10 metals, such as palladium and phosphine ligands, such as alkyl phosphines, cycloalkyl phosphines, aryl phosphines, pyridyl phosphines, or bidentate phosphines Carbonylation of ethylenically unsaturated compounds using carbon monoxide in the presence of a catalyst system has been described in a number of European patents and patent applications (see, for example, patent documents 1-13). In particular, it is disclosed that a bidentate phosphine ligand provides a catalyst system capable of achieving a high reaction rate (see, for example, Patent Documents 11 to 13). C3 alkyl bridges between phosphorus atoms and tertiary butyl substituents on the phosphorus are exemplified together (for example, Patent Document 13).

  Subsequently, certain groups of bidentate phosphine compounds containing tertiary carbon groups but having an aryl bridge can provide a significantly stable catalyst that requires little or no replenishment, the use of such bidentate catalysts has been (Eg, US Pat. No. 6,057,049) provides significantly higher reaction rates, little or no impurities are produced at high conversion rates, and the product is high relative to acid or ester products. It is disclosed that it has selectivity and does not produce a polymer (for example, Patent Document 14).

  Patent Document 15 describes the same method as Patent Document 14 and the rate when a ligand substituted with a tertiary carbon is used for a higher alkene in the presence of an aprotic solvent added from the outside. Is disclosed.

  U.S. Patent No. 6,057,031 discloses a modification of the bidentate phosphine used in U.S. Patent No. 6,057,028, whose tertiary carbon group is optionally substituted 2-phospha-tricyclo [3.3.1.1 { 3,7}] decyl group, or one or both phosphorus atoms incorporated in a derivative thereof (“2-PA” group) in which one or more of the carbon atoms are replaced by heteroatoms. Asymmetric ligands are envisioned but not exemplified. This example uses a symmetrical PA group that incorporates each phosphorus, and replaces each adjacent carbon of the PA group so that the carbon attached to the phosphorus is tertiary so that ethene, propene, and some higher Some alkoxycarbonylations of terminal and internal olefins are included. There is no use of secondary or primary carbon bonded to phosphorus. With respect to the carbonylation of the internal unsaturated olefins, improved rates and improved yields are seen compared to 1,3-bis (di-t-butylphosphino) propane.

  U.S. Patent No. 6,057,038 extends from the specific tertiary carbon phosphorus substituent ligand taught in U.S. Pat.

  U.S. Patent No. 6,057,051 describes that both of the previous types of ligand bridges are useful for butadiene carbonylation, and U.S. Patent No. 6,057,059 describes options of U.S. Patent No. 5,099,075 where tertiary The carbon substituents are different on each phosphorus atom, thus improving the reaction rate.

  By using primary, secondary and aromatic carbon substituents on the bidentate phosphorus ligand, no or no polymer product is produced in the carbonylation of certain ethylenically unsaturated compounds. It is known. General methods for producing polyketone polymers have been known for several years. Methods have been described that use bidentate phosphine ligands, including group VIII metals such as palladium, and acids having a pKa of less than 6 (e.g., Patent Documents 20-22). Preferred catalyst compositions for producing polyketone polymers include using palladium, a suitable acid and 1,3-bis (diphenylphosphine) propane or 1,3-bis [di (2-methoxyphenyl) phosphino] propane. Taught (for example, Patent Document 23).

For example, ligands substituted with aromatic groups such as 1,2-bis- (diphenylphosphino) propane and alkyl-substituted bidentate ligands bonded to phosphorus via —CH ₂ groups are Has been taught to produce polyketone polymer products with a range of molecular weights in good yields in the carbonylation of ethylene using, for example, US Pat.

  A ligand containing a cyclic group known as a phobane linked to phosphorus via a secondary carbon and containing an alkylene bridge, for example 9-phosphabicyclononane, shows good selectivity and is such It is known that non-polymer products can be produced in carbonylation reactions (eg, US Pat. An asymmetric bidentate phosphine ligand having a tertiary carbon on one phosphorus and a fovane secondary carbon on the other phosphorus is disclosed (for example, Patent Document 19). Of course, the reaction also shows good selectivity for the ester product.

European Patent Application No. 0055875 European Patent Application No. 04494872 European Patent Application No. 0106379 European Patent Application No. 0235864 European Patent Application No. 0274955 European Patent Application No. 0499329 European Patent Application No. 0386833 European Patent Application No. 0441447 European Patent Application No. 0 487 472 European Patent Application No. 0282142 European Patent Application No. 0227160 European Patent Application No. 0495547 European Patent Application No. 0495548 International Publication No. 96/19434 Pamphlet International Publication No. 01/65883 Pamphlet International Publication No. 98/42717 Pamphlet International Publication No. 03/070370 Pamphlet International Publication No. 04/103948 Pamphlet WO05 / 082830 pamphlet European Patent No. 121965 European Patent No. 181014 European Patent No. 213671 US Pat. No. 4,950,703 US Pat. No. 5,369,074 International Publication No. 01/87899 Pamphlet

  In the formation of acid or ester products or other products and other co-reactants, it is desirable not to have these because the polymer or oligomer product reduces yield and interferes with the reaction process .

  Thus, it is known to favor non-polymer / oligomer products in such reactions, particularly when carbonylating ethylenically unsaturated compounds that tend to polymerize to polyketones in the presence of carbon monoxide. It is important to select a locator. Surprisingly, a specific group of aromatic bridged asymmetric bidentate ligands, when combined with tertiary carbon substituents, are bidentate substituted with the above types of alkyl and aromatic groups. It has also been found here that the use of ligands does not produce a polymer product and that these ligands show improved stability in such reactions.

According to a first aspect of the present invention, a novel bidentate ligand according to claim 1 is provided.
According to a further aspect of the present invention, there is provided a catalyst system capable of catalyzing the carbonylation of ethylenically unsaturated compounds, the system comprising:
a) Group 8, 9 or 10 metal or a compound thereof,
b) can be obtained by combining a bidentate ligand of formula I, and c) an acid,
The ligand is present in at least a 2: 1 molar excess compared to the metal or the metal of the metal compound, and the acid is present in a at least 2: 1 molar excess compared to the ligand. ,

Where
A and B independently represent an optional lower alkylene linking group;
R represents a hydrocarbyl aromatic structure having at least one aromatic ring, through which the aromatic ring, if present, is via a respective linking group on an available adjacent atom of the at least one aromatic ring. Q ¹ and Q ² are combined,
The groups X ³ and X ⁴ independently represent a monovalent group of up to 30 atoms having at least one tertiary carbon atom, or X ³ and X ^{4 taken} together are at least two three Forming a divalent group of up to 40 atoms having a secondary carbon atom, each monovalent or divalent group being attached to the respective atom Q ¹ via the at least one or two tertiary carbon atoms. Combined
The groups X ¹ and X ² independently represent a monovalent group of up to 30 atoms having at least one primary, secondary or aromatic carbon atom, or X ¹ and X ^{2 taken} together Form a divalent group of up to 40 atoms having at least two primary, secondary or aromatic carbon atoms, each said monovalent or divalent group being said at least one or two primary, two Bonded to each atom Q ² via a primary or aromatic carbon atom (s),
Q ¹ and Q ² independently represent phosphorus, arsenic or antimony.

Advantageously, catalyst systems that utilize such ligands in carbonylation reactions, surprisingly, by combining the groups X ¹ and X ² and the Q ² atom via a non-tertiary carbon atom, are surprisingly Q ¹ And have been found to have improved stability over corresponding systems using tertiary carbon atoms bonded to both Q ² and Q ² . In general, the catalytic rotation number (TON) (metal mole / product mole) of the carbonylation reaction, in particular hydroxy- or alkoxy-carbonylation, is improved. In particular, TON is improved in reactions using recycled ligands compared to ligands in which X ¹ and X ² are bonded to the Q ² atom via a tertiary carbon atom. Preferably, the ligands of the present invention are utilized in continuous carbonylation reactions, although batch reactions, particularly repetitive batch reactions, may also be beneficial.

Therefore, according to the second aspect of the present invention, there is provided a method for carbonylation of an ethylenically unsaturated compound according to claim 2.
Preferably, the groups X ¹ and X ² are selected from C ₁ -C ₂₀ alkyl, C ₁ -C ₂₀ alkenyl, C ₁ -C ₂₀ alkynyl or C ₁ -C ₂₀ aryl groups.

It is particularly preferred that at least one of the radicals X ¹ or X ² contains a substituent. Preferably, the substituent is on the carbon directly attached to the Q ² atom or on the carbon adjacent to it. However substituents may be further away from Q ² atoms. For example, it may be separated from the Q ² atom by up to 5 carbon atoms. Thus, the carbon bonded to the Q ² atom is an aliphatic secondary carbon atom, or the alpha carbon relative thereto is an aliphatic secondary or tertiary carbon atom, or bonded to the Q ² atom. The carbon is preferably an aromatic carbon that forms part of an aromatic ring that is substituted at an appropriate position on the ring. Preferably in this case, the substituent is on the atom adjacent to the ring atom bonded to the Q ² atom.

Preferably, the further substituents are methyl, ethyl, n- propyl, iso - butyl t- butyl, _C 1 -C ₇ alkyl or _O-C 1 ~C ₇ alkyl group such as a methoxy or ethoxy group, or -CN, , -F, -Si (alkyl) ₃ , -COOR ⁶³ , -C (O)-or -CF ₃ , and R ⁶³ is alkyl, aryl or Het. Particularly preferred substituents are methyl, ethyl and propyl groups, especially methyl, methoxy or ethyl, more particularly methyl. The preferred range of _groups, C 1 -C ₇ alkyl or _O-C 1 ~C ₇ alkyl-substituted phenyl, in particular methyl, methoxy or ethyl phenyl group. In such phenyl embodiments, the substituent may be in the ortho, meta or para position of the ring, preferably in the ortho or meta position, most preferably in the ortho position.

Suitable X ¹ or X ² groups are prop-2-yl, phen-1-yl, 2-methyl-phen-1-yl, 2-methoxy-phen-1-yl, 2-fluoro-phen-1- Yl, 2-trifluoromethyl-phen-1-yl, 2-trimethylsilyl-phen-1-yl, 4-methyl-phen-1-yl, 3-methyl-phen-1-yl, but-2-yl, Pento-2-yl, pent-3-yl, 2-ethyl-phen-1-yl, 2-propyl-phen-1-yl and 2-prop-2′-yl-phen-1-yl.

  Preferably, in the process of the invention, the catalyst system also comprises an acid present in a molar excess of more than 2: 1 compared to the ligand, the ligand comprising the metal or the metal of the metal compound. Present in at least a 2: 1 molar excess compared to

Thus, according to the third aspect of the present invention, there is provided a catalyst system capable of catalyzing the carbonylation of ethylenically unsaturated compounds, the system comprising:
a) a Group 8, 9 or 10 metal or compound thereof;
b) a bidentate phosphine, arsine or stibine ligand of formula I as claimed herein;
c) can be obtained by optionally combining acids.

  Preferably, in a third aspect, the ligand is present in at least a 2: 1 molar excess compared to the metal or the metal of the metal compound, and the acid is compared to the ligand. Present in at least a 2: 1 molar excess.

  Suitably all of the components a) to c) of the catalyst system according to the invention can be added in situ to the reaction vessel in which the carbonylation is to take place. Alternatively, components a) -c) can be placed directly in the container in any order or in some specific order, either directly in the container, or added outside the container, and then formed to form the catalyst system. Can be placed in a container. For example, the acid component c) can be first added to the bidentate ligand component b) to form a protonated ligand, and then the protonated ligand can be converted to a metal or compound thereof (component a )) Can be added to form a catalyst system. Alternatively, the ligand component b) and the metal or compound thereof (component a)) can be mixed to form a chelated metal compound and then the acid (component c)) is added. Alternatively, any two components can be reacted together to form an intermediate portion, which can then be placed in a reaction vessel to contain a third component, or first reacted with a third component. Then put into the reaction vessel.

  As such, the present invention is such that the relative molar concentrations of both the bidentate ligand and the acid are above the levels previously envisaged, and thus the catalyst system is described herein in the carbonylation of ethylenically unsaturated compounds. It is directed to methods and catalyst systems that provide surprising and unexpected advantages when used in combination with the ligands defined above, and that reduce or at least reduce at least some of the disadvantages of prior art systems. In particular, the use of the catalyst system of the present invention is at least a more stable system, increased reaction rate, improved catalyst rotation speed, improved selectivity, improved conversion rate and polymerization in the carbonylation reaction of ethylenically unsaturated compounds. Bring about avoidance.

  As described above, the ligand is added to the catalyst system or precursor thereof in an amount such that the ratio of the ligand to the metal (ie, component b) to component a)) is a molar ratio of at least 2: 1. Exists. Preferably, the ratio of the ligand to the metal is greater than 2: 1 molar ratio, more preferably in the range 2: 1 to 1000: 1, even more preferably in the range 2.5: 1 to 1000: 1. , Even more preferably in the range of 3: 1 to 1000: 1, even more preferably in the range of 5: 1 to 750: 1, even more preferably in the range of greater than 5: 1 to 750: 1, even more preferably 5: More than 1 to 500: 1, even more preferably 10: 1 to 500: 1, even more preferably 20: 1 to 400: 1, even more preferably 50: 1 to 250: 1. A range, most preferably a range above 50: 1, for example 51: 1 or more, more particularly 51: 1 to 250: 1 or more to 1000: 1. Alternatively, the ratio may range from 15: 1 to 45: 1, preferably from 20: 1 to 40: 1, more preferably from 25: 1 to 35: 1.

  As mentioned above, the acid is present in the catalyst system or its precursor in an amount such that the ratio of the acid to the ligand (ie component c) to component b)) is at least a 2: 1 molar ratio. . Preferably, the ratio of acid to ligand is greater than 2: 1 molar ratio, more preferably in the range of 2: 1 to 100: 1, even more preferably in the range of 4: 1 to 100: 1, More preferably in the range of 5: 1 to 95: 1, even more preferably in the range of over 5: 1 to 95: 1, even more preferably in the range of over 5: 1 to 75: 1, more preferably 10: 1 to 1. In the range of 50: 1, even more preferably in the range of 20: 1 to 40: 1, even more preferably in the range of greater than 20: 1 to 40: 1 (eg 25: 1 to 40: 1 or 25: 1 to 30 Less than 1), most preferably greater than 30: 1, and suitably any of the upper limits are those previously presented herein (eg, 30: 1 to 40: 1).

“Acid” means an acid or salt thereof, and references to an acid should be construed accordingly.
The advantages of working within the aforementioned ligand-to-metal and acid-to-ligand ratios are further enhanced by the stability of the catalyst system, as evidenced by the increased catalyst turnover number (TON) of the metal. Appears to improve. By improving the stability of the catalyst system, the use of metals in the carbonylation reaction scheme is minimized.

  Without being bound by any theory, by acting within the specific ratios described herein, it is surprising that the ligand components of the catalyst system are protected from inadvertent air oxidation ( It may be found that, for example, if the reaction system has air intrusion), the overall stability of the catalyst system is improved and thus the use of metal components in the catalyst system can be minimized. Even more surprising is that the previous reaction rate of the reactants is improved.

  In fact, the acid concentration should be matched to the particular bidentate ligand used, and the acid concentration should be such that the phosphine, arsine or stibine is fully protonated. Therefore, to show an improvement in effect, the concentration of the ligand should be somewhat above the minimum concentration, as given by the ligand: metal molar ratio, and the acid concentration should be As given by the ratio, it should be somewhat above the minimum concentration relative to the concentration of ligand present to promote protonation.

  Preferably, the acid has a molar ratio of said acid to said metal (ie component c) to component a)) in the catalyst system or precursor thereof is at least 4: 1, more preferably 4: 1 to 100,000: 1, Even more preferably 10: 1 to 75000: 1, even more preferably 20: 1 to 50000: 1, even more preferably 25: 1 to 50000: 1, and even more preferably 30: 1 to 50000: 1, Even more preferably 40: 1 to 40000: 1, even more preferably 100: 1 to 25000: 1, even more preferably 200: 1 to 25000: 1, most preferably 550: 1 to 20000: 1, or It is present in an amount greater than 2000: 1 to 20000: 1. Alternatively, the ratio is 125: 1 to 485: 1, more preferably 150: 1 to 450: 1, even more preferably 175: 1 to 425: 1, and even more preferably 200: 1 to 400: 1, most preferably Preferably it may be in the range of 225: 1 to 375: 1.

For clarity, all of the above ratios and ratio ranges apply to all of the ligand embodiments detailed further herein below.
Still further, using the ligands of the present invention to optimize the TON using the system described above, the surprising reusability and polymerization reduction found for the ligands of the present invention. Becomes more obvious.

Cross-linking group R
Preferably, as defined, the group R bonded to A and B on an available adjacent atom of at least one aromatic ring is also one or more additional aromatic ring atom (s) of the aromatic structure. Substituted with one or more substituent (s) Y ^x above. Preferably, the substituent (s) Y ^x on the aromatic structure has a total ^{x = 1 to n} ΣtY ^x of atoms other than hydrogen such that ^{x = 1 to n} ΣtY ^x ≧ 4, n is the total number of substituent (s), and Y ^x and tY ^x represent the total number of atoms other than hydrogen on a particular substituent Y ^x .

In general, when two or more substituents are present, Y ^x is hereinafter also simply referred to as Y, and any two can be located on the same or different aromatic ring atoms of the aromatic structure. Preferably, there are ≦ 10 Y groups on the aromatic structure (ie n is 1-10), more preferably 1-6 Y groups, most preferably 1-4 Y groups. Present, in particular 1, 2 or 3 substituent Y groups on the aromatic structure. The substituted ring aromatic atom may be carbon or hetero, but is preferably carbon.

Preferably, ^{x = 1 to n} ΣtY ^x is between 4 and 100, more preferably between 4 and 60, most preferably between 4 and 20, especially between 4 and 12.
Preferably, when one substituent Y is present, Y represents a group that is at least as sterically hindered as phenyl, and when more than one substituent Y is present, they are as sterically hindered as phenyl. And / or they combine to form a group that is more sterically hindered than phenyl.

As used herein, steric hindrance means a term as readily understood by one of ordinary skill in the art, whether in the context of the groups R ^{1 to} R ¹² described below or in the context of the substituent Y. To describe, the term sterically hindered than phenyl is used when PH ₂ Y (representing the group Y) reacts with Ni (O) (CO) ₄ in an 8-fold excess in accordance with the following conditions: _It can be taken to mean having a degree of substitution (DS) lower than ₂ Ph. Similarly, steric hindrance more than t-butyl can be interpreted as a reference to a DS value compared to PH ₂ t-Bu and the like. If PHY ¹ is not as sterically hindered as the reference when comparing two Y groups, PHY ¹ Y ² should be compared to that reference. Similarly, PY ¹ Y ² Y ³ should be compared if PHY ¹ or PHY ¹ Y ² has not yet been determined to be more sterically hindered than the standard when comparing 3 Y groups. If more than 4 Y groups are present, they should be interpreted as being more sterically hindered than t-butyl.

  The steric hindrance in the context of the present invention is referred to herein as “Homogenous Transition Metal Catalysis-A Gentle Art” by C. Masters, published in 1981 by Chapman and Hall. Page (see below).

  Tolman ("Phosphorus Ligand Exchange Equilibria on Zerovalent Nickel. A Dominant Role for Strategic Effects, Vol. 29, Journal of American Chem. 29, Journal of American Chem. 29, Journal of American Chem. We conclude that the characteristics of the ligands that are primarily determined are their size rather than their electrical characteristics.

To determine the relative steric hindrance of the group Y, the Tolman method for determining the DS can be used for the phosphorus analog of the group determined as described above.
A toluene solution of Ni (CO) ₄ was treated with an 8-fold excess of a phosphorus ligand, after which CO was replaced by the ligand using carbonyl stretching vibrations in the infrared spectrum. The solution was equilibrated by heating in a sealed tube at 100 ° for 64 hours. Upon further heating at 100 ° for 74 hours, there was no significant change in the spectrum. The frequency and intensity of the carbonyl stretch band of the spectrum of the equilibration solution is then determined. The degree of substitution can be estimated semi-quantitatively from the relative intensity and from the assumption that the band attenuation coefficients are all of the same magnitude. For _example, in the case of _{P (C 6 H 11) 3} , Ni (CO) 3 B 1 band _{A 1} band and Ni _{(CO) 2 L} 2 of L is approximately the same intensity, therefore the degree of substitution 1.5 It is guessed. If each ligand in this experiment can not distinguish, diphenyl phosphorus PPh 2 _H or di -t- butyl phosphoric, in some cases should be compared with PY 2 _H equivalents. Furthermore, when it is not possible to still distinguish the ligands in the experiment, the PPh ₃ or ^P (t _{Bu) 3} ligand, as the case should be compared with the PY _3. Such further experimentation may require small ligands which fully replace the Ni (CO) ₄ complex.

  The group Y can also be defined by reference to its cone angle, which in the context of the present invention can be defined as the apex angle of a cone centered on the midpoint of the aromatic ring. An intermediate point means a point in the plane of the ring that is equidistant from a cyclic ring atom.

  Preferably, the cone angle of at least one group Y or the sum of the cone angles of two or more Y groups is at least 10 °, more preferably at least 20 °, most preferably at least 30 °. The cone angle is the Tolman method {C., except that the apex angle of the cone is centered on the midpoint of the aromatic ring. A. Tolman Chem. Rev. 77 (1977), pp. 313-348}. This modification of the use of Tolman cone angle has been used in other systems for measuring steric effects such as those in cyclopentadienyl zirconium ethene polymerization catalysts (Journal of Molecular Catalysis: Chemical 188, (2002)). 105-113).

Substituent Y is selected to be sized appropriately to provide steric hindrance to the active site between the Q ¹ and Q ² atoms. However, it is not known whether the substituents prevent metal detachment and guide it into its insertion pathway, resulting in a generally more stable catalyst confirmation or otherwise acting.

Particularly preferred ligands are found when Y represents —SR ⁴⁰ R ⁴¹ R ⁴² , S represents Si, C, N, S, O or aryl, and R ⁴⁰ R ⁴¹ R ⁴² is defined herein. As defined below. Preferably each Y and / or combination of two or more Y groups is at least as sterically hindered as t-butyl.

  More preferably, when only one substituent Y is present, Y is at least as sterically hindered as t-butyl, and when more than one substituent Y is present when considered as a single group They are each at least as sterically hindered as phenyl and at least as sterically hindered as t-butyl.

Preferably, when S is aryl, R ⁴⁰ , R ⁴¹ and R ⁴² are independently hydrogen, alkyl, —BQ ³ —X ³ (X ⁴ ) (B, X ³ and X ⁴ are as defined herein. Q ³ is defined as Q ¹ or Q ² above), phosphorus, aryl, arylene, alkaryl, arylene alkyl, alkenyl, alkynyl, het, hetero, halo, cyano, nitro, ^{-OR 19, -OC (O) R} 20, -C (O) R 21, -C (O) OR 22, -N (R 23) R 24, -C (O) N (R 25) R 26, ^{-SR 29, -C (O) SR} 30, -C (S) N (R 27) R 28, -CF 3, a ^-SiR 71 ^R 72 ^{R 73} or alkyl phosphate.

R ^{19 to} R ³⁰ referred to herein can generally be independently selected from hydrogen, unsubstituted or substituted aryl or unsubstituted or substituted alkyl, and R ²¹ can be nitro, halo, amino or thio It may be.

Preferably, when S is Si, C, N, S or O, R ⁴⁰ , R ⁴¹ and R ⁴² are independently hydrogen, alkyl, phosphorus, aryl, arylene, alkaryl, aralkyl, arylenealkyl, alkenyl. , Alkynyl, het, hetero, halo, cyano, nitro, —OR ¹⁹ , —OC (O) R ²⁰ , —C (O) R ²¹ , —C (O) OR ²² , —N (R ²³ ) R ²⁴ , ^{-C (O) N (R 25} ) R 26, -SR 29, -C (O) SR 30, -C (S) N (R 27) R 28, -CF 3, -SiR 71 R 72 R 73 or Is an alkyl phosphorus, at least one of R ^{40 to} R ⁴² is not hydrogen, R ^{19 to} R ³⁰ are as defined herein, and R ^{71 to} R ⁷³ are as R ^{40 to} R ^42. Defined but good Properly is _C 1 -C ₄ alkyl or phenyl.

Preferably S is Si, C or aryl. However, N, S or O may be preferred as one or more of the combined Y groups or in the case of multiple Y groups. For clarity, R ^{40 to} R ⁴² may be a lone pair if oxygen or sulfur can be divalent.

Preferably, in addition to the group Y, the aromatic structure may be unsubstituted or, where possible, Y (on a non-aromatic ring atom), alkyl, aryl, arylene, alkaryl, aralkyl, arylenealkyl, alkenyl , Alkynyl, het, hetero, halo, cyano, nitro, —OR ¹⁹ , —OC (O) R ²⁰ , —C (O) R ²¹ , —C (O) OR ²² , —N (R ²³ ) R ²⁴ , ^{-C (O) N (R 25} ) R 26, -SR 29, -C (O) SR 30, -C (S) N (R 27) R 28, -CF 3, -SiR 71 R 72 R 73 or May be further substituted with a group selected from alkyl phosphorus, R ^{19 to} R ³⁰ are as defined herein, and in the case of Y or a group that satisfies the definition of Y in the first embodiment, The bond is an aromatic non-ring R ^{71 to} R ⁷³ are defined as R ^{40 to} R ⁴² , and preferably C _{1 to} C ₄ alkyl or phenyl. Further, the at least one aromatic ring may be part of a metallocene complex, such as ferrocenyl, ruthenosyl, molybdenocenyl, or indenyl equivalents when R is a cyclopentadienyl or indenyl anion, etc. A part of the metal complex can be formed.

Such complexes should be regarded as aromatic structures that are included in the context of the present invention, and therefore when they contain more than one aromatic ring, the substituent (s) Y ^x is Q ¹ and Q It may be on the same aromatic ring to which the ^two atoms are bonded or on an additional aromatic ring of that structure. For example, in the case of a metallocene, the substituent Y ^x may be on any one or more rings of the metallocene structure, which may be the same or different ring to which Q ¹ and Q ² are attached.

  Suitable metallocene type ligands that can be substituted with the group Y defined herein are known to those skilled in the art and are broadly defined in WO 04/024322. A particularly preferred Y substituent for such aromatic anions is Y when S is Si.

In general, however, when S is aryl, the aryl may be unsubstituted, or in addition to R ⁴⁰ , R ⁴¹ , R ⁴² and any of the additional substituents defined above for the aromatic structure. May be substituted.

More preferred Y substituents in the present invention, such as -t- butyl t- alkyl or t- alkyl, aryl or 2-phenylprop-2-yl, -SiMe _3,, - phenyl, alkylphenyl -, phenylalkyl - Alternatively, it can be selected from phosphinoalkyl- such as phosphinomethyl.

Preferably, when S is Si or C and one or more of R ^{40 to} R ⁴² is hydrogen, at least one of R ^{40 to} R ⁴² should be bulky enough to obtain the required steric hindrance And such groups are preferably phosphorus, phosphinoalkyl-, tertiary carbon-bearing groups such as -t-butyl, -aryl, -alkaryl, -aralkyl or tertiary silyl.

  Preferably, when the hydrocarbyl aromatic structure is not a metallocene complex, it contains 5 to a maximum of 70 ring atoms, more preferably 5 to 40 ring atoms, most preferably 5 to 22 ring atoms, including substituents, In particular it has 5 or 6 ring atoms.

Preferably, the hydrocarbyl aromatic structure may be monocyclic or polycyclic. Cyclic aromatic atoms may be carbon or hetero, and references to them herein are references to sulfur, oxygen and / or nitrogen. However, it is preferred that the Q ¹ and Q ² atoms are bonded to available adjacent cyclic carbon atoms of at least one aromatic ring. In general, when the cyclic hydrocarbyl structure is polycyclic, it is preferably bicyclic or tricyclic. The additional rings in the aromatic structure may or may not themselves be aromatic and the aromatic structure should be understood accordingly. The non-aromatic cyclic ring (s) as defined herein can contain unsaturated bonds. A ring atom means an atom that forms part of the ring skeleton.

Preferably, the bridging group -R (Y ^x) _n is further substituted, even otherwise, preferably 200 fewer than atoms, more preferably fewer than 150 atoms, more preferably less than 100 Of atoms.

The term one additional aromatic ring atom of an aromatic structure means any additional aromatic ring atom of the aromatic structure, which is bonded to a Q ¹ or Q ² atom via a linking group. Is not an available adjacent ring atom of at least one aromatic ring.

Preferably, directly adjacent ring atoms on either side of the available adjacent ring atoms are preferably unsubstituted. As an example, an aromatic phenyl ring bonded to the Q ¹ atom via the 1-position on the ring and to the Q ² atom via the 2-position on the ring is preferably the 4-position of the ring and / or Having one or more said further aromatic ring atoms substituted in the 5-position and two ring atoms directly adjacent to said available adjacent ring atoms not substituted in the 3- and 6-positions. However, this is merely a preferred substituent sequence, for example, and substitutions at the 3 and 6 positions are possible.

The term aromatic ring means that at least one ring to which Q ¹ or Q ² atoms are bonded via B and A, respectively, is aromatic, which is preferably phenyl, cyclopentadi Including not only the structures of the types of anenyl anion, pyrrolyl, pyridinyl but also other rings with aromaticity, such as those found in any ring with delocalized π electrons that can move freely in the ring, Should be interpreted.

Preferred aromatic rings have 5 or 6 atoms in the ring, but rings with 4n + 2π electrons, such as [14] annulene, [18] annulene, are possible.
The hydrocarbyl aromatic structure R is benzene-1,2, diyl, ferrocene-1,2-diyl, naphthalene-2,3-diyl, 4 or 5 methylbenzene-1,2-diyl, 1′-methylferrocene-1, 2-diyl, 4 and / or 5-t-alkylbenzene-1,2-diyl, 4,5-diphenyl-benzene-1,2-diyl, 4 and / or 5-phenyl-benzene-1,2-diyl, 4,5-di-t-butyl-benzene-1,2-diyl, 4 or 5-tbutylbenzene-1,2-diyl, 2,3,4 and / or 5-t-alkyl-naphthalene-8, 9-diyl, 1H-indene-5,6-diyl, 1,2 and / or 3methyl-1H-indene-5,6-diyl, 4,7methano-1H-indene-1,2-diyl, 1, 2 and And / or 3-dimethyl-1H-indene 5,6-diyl, 1,3-bis (trimethylsilyl) -isobenzofuran-5,6-diyl, 4- (trimethylsilyl) benzene-1,2 diyl, 4-phosphino Methylbenzene-1,2diyl, 4- (2'-phenylprop-2'-yl) benzene-1,2diyl, 4-dimethylsilylbenzene-1,2diyl, 4-di-t-butyl, methylsilyl Benzene-1,2diyl, 4- (t-butyldimethylsilyl) -benzene-1,2diyl, 4-t-butylsilyl-benzene-1,2diyl, 4- (tri-t-butylsilyl) -benzene-1 , 2 diyl, 4- (2′-tert-butylprop-2′-yl) benzene-1,2 diyl, 4- (2 ′, 2 ′, 3 ′, 4 ′, 4′pentamethyl-pent-3′- Il)-Be Zen-1,2diyl, 4- (2 ′, 2 ′, 4 ′, 4′-tetramethyl, 3′-t-butyl-pent-3′-yl) -benzene-1,2diyl, 4- ( Or 1 ′) t-alkylferrocene-1,2-diyl, 4,5-diphenyl-ferrocene-1,2-diyl, 4- (or 1 ′) phenyl-ferrocene-1,2-diyl, 4,5- Di-t-butyl-ferrocene-1,2-diyl, 4- (or 1 ′) t-butylferrocene-1,2-diyl, 4- (or 1 ′) (trimethylsilyl) ferrocene-1,2-diyl, 4 -(Or 1 ') phosphinomethylferrocene-1,2diyl, 4- (or 1') (2'-phenylprop-2'-yl) ferrocene-1,2diyl, 4- (or 1 ') dimethyl Silylferrocene-1,2-diyl, 4- (or 1 ') di-t- Butyl, methylsilylferrocene-1,2diyl, 4- (or 1 ') (t-butyldimethylsilyl) -ferrocene-1,2 diyl, 4- (or 1') t-butylsilyl-ferrocene-1,2 diyl 4- (or 1 ′) (tri-t-butylsilyl) -ferrocene-1,2 diyl, 4- (or 1 ′) (2′-tert-butylprop-2′-yl) ferrocene-1,2 diyl, 4- (or 1 ′) (2 ′, 2 ′, 3 ′, 4 ′, 4′pentamethyl-pent-3′-yl) -ferrocene-1,2 diyl, 4- (or 1 ′) (2 ′, 2 ', 4', 4'-tetramethyl, 3'-t-butyl-pent-3'-yl) -ferrocene-1,2 diyl.

As used herein, a structure in which two or more possible stereoisomers are present is contemplated for all such stereoisomers.
As described above, in some embodiments, two or more of the Y and / or non-Y substituents on additional aromatic ring atoms of the aromatic structure may be present. In some cases, the two or more substituents may be combined to form additional ring structures, such as alicyclic ring structures, particularly when they are on adjacent cyclic aromatic atoms. .

Such alicyclic ring structures may be saturated or unsaturated, bridged or unbridged, alkyl, Y group as defined herein, aryl, arylene, alkaryl, aralkyl, arylene alkyl, alkenyl, alkynyl, het , Hetero, halo, cyano, nitro, —OR ¹⁹ , —OC (O) R ²⁰ , —C (O) R ²¹ , —C (O) OR ²² , —N (R ²³ ) R ²⁴ , —C (O ) N (R ²⁵ ) R ²⁶ , —SR ²⁹ , —C (O) SR ³⁰ , —C (S) N (R ²⁷ ) R ²⁸ , —CF ₃ , —SiR ⁷¹ R ⁷² R ⁷³ or phosphinoalkyl Optionally substituted (if present, at least one of R ^{40 to} R ⁴² is not hydrogen, R ^{19 to} R ³⁰ are as defined herein, R ^{71 to} R ⁷³ are R ^40- R ⁴² and And preferably is C ₁ -C ₄ alkyl or phenyl) and / or by one or more (preferably less than 4 total) oxygen, nitrogen, sulfur, silicon atoms, or silano Alternatively, it may be blocked by a dialkyl silicon group or a mixture thereof.

  Examples of such structures include piperidine, pyridine, morpholine, cyclohexane, cycloheptane, cyclooctane, cyclononane, furan, dioxane, DIOP substituted with alkyl, 1,3-dioxane substituted with 2-alkyl, cyclopenta Non, cyclohexanone, cyclopentene, cyclohexene, cyclohexadiene, 1,4 dithiane, piperidine, pyrrolidine, thiomorpholine, cyclohexenone, bicyclo [4.2.0] octane, bicyclo [4.3.0] nonane, adamantane, tetrahydro Pyran, dihydropyran, tetrahydrothiopyran, tetrahydro-furan-2-one, deltavalerolactone, γ-butyrolactone, glutaric anhydride, dihydroimidazole, triazacyclononane, triazacyclode , Thioazolidine, hexahydro-1H-indene (5,6 diyl), octahydro-4,7 methano-indene (1,2 diyl) and tetrahydro-1H-indene (5,6 diyl), all of which As defined herein for aryl, it may be unsubstituted or substituted.

However, whether forming a combination of groups or otherwise, directly adjacent aromatic ring atoms on either side of the available adjacent ring atoms to which Q ¹ or Q ² are attached via the linking group Is preferably unsubstituted, and preferred substituents are somewhere on at least one aromatic ring, or somewhere in the aromatic structure if the aromatic structure contains more than one aromatic ring, The preferred position of the combination of Y substituents should be understood accordingly.

Non-limiting examples of unsubstituted and substituted aromatic bridged bidentate ligands included in the present invention are set forth in the claims.
Alternatively, further examples of unsubstituted and substituted aromatic bridged bidentate ligands include phenyl, isopropyl, o-ethylphenyl and o-methoxyphenyl analogs of the aforementioned o-tolyl ligand, ie 1- (di -Tert-butylphosphinomethyl) -2- (diphenylphosphinomethyl) benzene and the like.

  In the previous list of ligands, the term “phosphinomethyl-adamantyl” means any one of the following groups: 2-phosphinomethyl-1,3,5,7-tetramethyl-6,9,10-trioxatricyclo- {3.3.1.1 [3.7]} decyl, 2-phosphinomethyl- 1,3,5-trimethyl-6,9,10-trioxatricyclo- {3.3.1.1 [3.7]} decyl 2-phosphinomethyl-1,3,5,7-tetra ( Trifluoromethyl) -6,9,10-trioxatricyclo- {3.3.1.1 [3.7]} decyl, 2-phosphinomethylperfluoro-1,3,5,7-tetramethyl- 6,9,10-trioxatricyclo {3.3.1.1 [3.7]}-decyl or 2-phosphinomethyl-1,3,5-tri (trifluoromethyl) -6,9, 10-trioxatricyclo- {3.3.1.1 [3.7]} decyl.

  In the previous list of ligands, the term “phospha-adamantyl” means any one of the following groups: 2-phospha-1,3,5,7-tetramethyl-6,9,10-trioxatricyclo- {3.3.1.1 [3.7]} decyl, 2-phospha-1,3,3 5-trimethyl-6,9,10-trioxatricyclo- {3.3.1.1 [3.7]} decyl, 2-phospha-1,3,5,7-tetra (trifluoromethyl)- 6,9,10-trioxatricyclo- {3.3.1.1 [3.7]} decyl, perfluoro (2-phospha-1,3,5,7-tetramethyl-6,9,10- Trioxatricyclo {3.3.1.1 [3.7]}-decyl or 2-phospha-1,3,5-tri (trifluoromethyl) -6,9,10-trioxatricyclo- { 3.3.1.1 [3.7]} decyl.

  For clarity, 2-phosphinomethyl-1,3,5,7-tetramethyl-6,9,10-trioxatricyclo- {3.3.1.1 [3.7]} The structure of decyl and the like is as follows.

  Similarly, the structure of 2-phospha-1,3,5,7-tetramethyl-6,9,10-trioxatricyclo- {3.3.1.1 [3.7]} decyl has the structure Street.

In all cases, it will be understood that the phosphorus is attached to the two tertiary carbon atoms of the phospha-adamantyl skeleton.
Selected structures of the ligands of the present invention include the following:

1- (di-tert-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) benzene,

1- (di-tert-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) ferrocene,

1- (di-t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4,5-diphenylbenzene,

(Where oT | y | represents o-tolyl)
1- (P, P adamantyl, t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4,5-diphenylbenzene,

1- (di-o-tolylphosphinomethyl) -2- (di-tert-butylphosphino) -4- (trimethylsilyl) benzene,

1- (di-t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4,5-diphenylferrocene is included.
In the precedent structure of the ligand, one or more of the t 1 -butyl bonded to the phosphorus of the X ¹ -X ⁴ tertiary carbon support group, Q ¹ and / or Q ² groups is replaced by a suitable alternative be able to. Preferred alternatives are adamantyl, 1,3 dimethyladamantyl, congressyl, norbornyl or 1-norbondienyl, or X ¹ and X ² together and / or X ³ and X ⁴ together and phosphorus 2-phospha-1,3,5,7-tetramethyl-6,9,10-trioxoadamantyl or 2-phospha-1,3,5-trimethyl-6,9,10- Forms 2-phospha-tricyclo [3.3.1.1 {3,7} decyl groups such as trioxoadamantyl. In most embodiments, it is preferred combinations of X ¹ to X ⁴ group or X ^{1 /} X ² and X ^{3 /} X ⁴ groups are the same, in general in the present invention, are those selected ligands It may also be advantageous to use different groups to provide asymmetry around the active site.

  Similarly, one of the linking groups A or B may not be present as shown in some of the previous structures, so that only A or B is methylene and the phosphorous is not bound to a methylene group. The atoms are directly bonded to a ring carbon that provides a three carbon bridge between the phosphorus atoms.

Substituent X ^1-4
Given the limitations defined in the claims, the substituents ^X1-4 can represent various groups. For example, the group X ¹ can represent CH (R ² ) (R ³ ), X ² can represent CH (R ⁴ ) (R ⁵ ), and X ³ can be CR ⁷ (R ⁸ ) (R ⁹ ), X ⁴ can represent CR ¹⁰ (R ¹¹ ) (R ¹² ), R ^{2 to} R ⁵ represent hydrogen, alkyl, aryl or het, and R ^{7 to} R ¹² represent Represents alkyl, aryl or het. Alternatively, X ¹ represents Ar and / or X ² represents Ar. Preferably, when X ¹ and / or X ² represents Ar, the group is a C ₁ -C ₇ alkyl group, an O—C ₁ -C ₇ alkyl group, —CN, —F, —Si (alkyl) ₃ , -COO alkyl, -C (O) - which is substituted by or -CF _3. Preferably, the Ar group is substituted at the carbon adjacent to the ring carbon attached to Q, ie at the ortho position of the phenyl ring.

Particular preference is given to t- when the organic radicals R ^{7 to} R ⁹ and / or R ^{10 to} R ¹² or R ^{7 to} R ¹² are bonded to their respective tertiary carbon atom (s). This is the case when forming a complex group that is at least as sterically hindered as butyl (s).

Steric groups can be cyclic, partially cyclic or acyclic. When cyclic or partially cyclic, the group can be substituted or unsubstituted, or saturated or unsaturated. Cyclic or partially cyclic groups preferably contain tertiary carbon atom (s) in the ring structure, C ₄ -C ₃₄ , more preferably C ₈ -C ₂₄ , most preferably C ₁₀ -C. It can contain ₂₀ carbon atoms. The cyclic structure is halo, cyano, nitro, OR ¹⁹ , OC (O) R ²⁰ , C (O) R ²¹ , C (O) OR ²² , NR ²³ R ²⁴ , C (O) NR ²⁵ R ²⁶ , SR ²⁹ , C (O) SR ³⁰ , C (S) NR ²⁷ R ²⁸ , optionally substituted by one or more substituents selected from aryl or Het (R ^{19 to} R ³⁰ are independently Represents hydrogen, aryl or alkyl), and / or may be blocked by one or more oxygen or sulfur atoms, or by silano or dialkylsilicon groups.

In particular, when cyclic, X ³ and / or X ⁴ can represent congresyl, norbornyl, 1-norbornadienyl or adamantyl.
X ³ and X ⁴ together with Q ^{1 to} which they are attached, represents an optionally substituted 2-Q1-tricyclo [3.3.1.1 {3,7}] decyl group or derivative thereof. Or X ³ and X ⁴ can be taken together with Q ^{1 to} which they are attached to form a ring system of formula 1b.

Alternatively, one or more of the groups X ³ and / or X ⁴ can represent the solid phase to which the ligand is bound.
Particularly preferred is when X ³ and X ⁴ are the same and X ¹ and X ² are the same.

In a preferred embodiment, R ^{2 to} R ⁵ independently represent hydrogen, alkyl, aryl or Het, R ^{7 to} R ¹² independently represent alkyl, aryl or Het,
R ^{19 to} R ³⁰ independently represent hydrogen, alkyl, aryl or Het;
R ⁴⁹ and R ⁵⁴ , when present, independently represent hydrogen, alkyl or aryl;
R ^{50 to} R ⁵³ , when present, independently represent alkyl, aryl or Het;
YY ^2, if present, independently represent oxygen, sulfur or ^{N-R 55, R 55} represents hydrogen, alkyl or aryl.

Preferably, R ^{2 to} R ⁵ and R ^{7 to} R ¹² independently represent alkyl or aryl when not hydrogen. More preferably, R ² -R ⁵ and R ⁷ -R ¹² are independently C ₁ -C ₆ alkyl, C ₁ -C ₆ alkylphenyl (the phenyl group is optionally substituted with aryl as defined herein). Or phenyl (the phenyl group is optionally substituted with aryl as defined herein). Even more preferably, R ² -R ⁵ and R ⁷ -R ¹² independently represent C ₁ -C ₆ alkyl, which is optionally substituted with alkyl as defined herein. Most preferably, R ^{2 to} R ⁵ and R ^{7 to} R ¹² are each methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, tert-butyl, pentyl, hexyl and cyclohexyl, especially methyl Represents unsubstituted C ₁ -C ₆ alkyl.

In one particularly preferred embodiment of the invention, R ⁴ , R ⁷ and R ¹⁰ each represent the same alkyl, aryl or Het moiety as defined herein, and R ² , R ⁵ , R ⁸ and R ¹¹ are each Represent the same alkyl, aryl or Het moiety as defined herein, and R ³ , R ⁹ and R ¹² each represent the same alkyl, aryl or Het moiety as defined herein. More preferably R ⁴ , R ⁷ and R ¹⁰ are each the same C ₁ -C such as methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, tert-butyl, pentyl, hexyl or cyclohexyl. ₆ alkyl, especially unsubstituted C ₁ -C ₆ alkyl, R ² , R ⁵ , R ⁸ and R ¹¹ independently represent the same C ₁ -C ₆ alkyl as defined above, R ³ , R ⁹ And R ¹² independently represent the same C ₁ -C ₆ alkyl as defined above. For example, R ⁴ , R ⁷ and R ¹⁰ each represent methyl, R ² , R ⁵ , R ⁸ and R ¹¹ each represent ethyl, and R ³ , R ⁹ and R ¹² each represent n-butyl or n-pentyl. Represents.

In one particularly preferred embodiment of the invention, each R ^{2 to} R ⁵ and R ^{7 to} R ¹² group represents the same alkyl, aryl or Het moiety as defined herein. Preferably, when an alkyl group, each ^R 1 ^{to R 12} include methyl, ethyl, n- propyl, iso - propyl, n- butyl, iso - butyl, tert- butyl, pentyl, same C of hexyl and cyclohexyl ₁ -C ₆ alkyl group, particularly an unsubstituted _C 1 -C ₆ alkyl. More preferably, each R ^{1 to} R ¹² represents methyl or tert-butyl, most preferably methyl.

The term “lower alkylene” represented by A and B in a compound of formula I, as used herein, is attached at two positions on the group, thereby linking the group Q ¹ or Q ² to the R group. Includes C ₁ -C ₁₀ groups that can be attached, otherwise defined as “alkyl” below. Nevertheless, methylene is most preferred. In the optional case with respect to A and B, it means that the group Q ¹ or Q ² can be bonded directly to the R group and there is an option that there is no C ₁ -C ₁₀ lower alkylene group as an intermediate. To do. However, in this case, at least one of A and B is not optionally deleted, and is preferably C ₁ -C ₁₀ lower alkylene. In any case, if one of the groups A or B is not present in some cases, preferably there are other groups, said other group can represent a C ₁ -C ₁₀ group as defined herein, Therefore it is preferable that at least one of a and B is a _C 1 _{-C 10} "lower alkylene" groups.

The term “alkyl” as used herein means C ₁ -C ₁₀ alkyl, unless otherwise specified, and includes methyl, ethyl, propyl, butyl, pentyl, hexyl and heptyl groups. . Unless otherwise specified, an alkyl group is straight or branched (particularly preferred branching groups include t-butyl and isopropyl), saturated or unsaturated, cyclic, acyclic when a sufficient number of carbon atoms are present May be formula or partially cyclic / acyclic, unsubstituted, halo, cyano, nitro, OR ¹⁹ , OC (O) R ²⁰ , C (O) R ²¹ , C (O) OR ²² , NR ²³ One selected from R ²⁴ , C (O) NR ²⁵ R ²⁶ , SR ²⁹ , C (O) SR ³⁰ , C (S) NR ²⁷ R ²⁸ , unsubstituted or substituted aryl, or unsubstituted or substituted Het or may be substituted by a plurality of substituents, in may have terminated (R ¹⁹ to R ³⁰ are independently hydrogen, halo, unsubstituted or substituted aryl or unsubstituted or substituted alkyl And, or, in the case of R ²¹ is halo, nitro, cyano and an amino), and / or one or more (preferably less than 4) oxygen, sulfur, by a silicon atom, or silano or dialkyl silicon groups Or it may be blocked by a mixture thereof.

The term “Ar” or “aryl” as used herein is a 5- to 10-membered, preferably 5- to 8-membered carbocyclic ring, such as phenyl, cyclopentadienyl and indenyl anions and naphthyl. Comprising an aromatic or pseudoaromatic group of the formula, which group may be unsubstituted or unsubstituted or substituted aryl, alkyl (this group is itself unsubstituted as defined herein) Optionally substituted, optionally terminated, Het (this group may itself be unsubstituted, optionally substituted, terminated as defined herein) Halo, cyano, nitro, OR ¹⁹ , OC (O) R ²⁰ , C (O) R ²¹ , C (O) OR ²² , NR ²³ R ²⁴ , C (O) NR ²⁵ R ²⁶ , ^SR 29, C (O) R ³⁰ or C ^(S) may be substituted with one or more substituents selected from ^{NR 27 R 28, R 19 ~R} 30 are independently hydrogen, unsubstituted or substituted aryl or alkyl ( The alkyl group represents itself unsubstituted, substituted, optionally terminated, as defined herein), or in the case of R ²¹ halo, nitro Represents cyano or amino.

The term “alkenyl” as used herein means C ₂ -C ₁₀ alkenyl and includes ethenyl, propenyl, butenyl, pentenyl and hexenyl groups. Unless otherwise specified, an alkenyl group is straight or branched, saturated or unsaturated, cyclic, acyclic or partially cyclic / acyclic, unsubstituted, when a sufficient number of carbon atoms are present. Halo, cyano, nitro, OR ¹⁹ , OC (O) R ²⁰ , C (O) R ²¹ , C (O) OR ²² , NR ²³ R ²⁴ , C (O) NR ²⁵ R ²⁶ , SR ²⁹ , Optionally terminated by one or more substituents selected from C (O) SR ³⁰ , C (S) NR ²⁷ R ²⁸ , unsubstituted or substituted aryl, or unsubstituted or substituted Het may also be (R ¹⁹ to R ³⁰ is a is as previously defined for alkyl), and / or one or more (less than preferably four) oxygen, sulfur, by a silicon atom, or It may be interrupted by Rano or dialkyl silicon groups or mixtures thereof.

The term “alkynyl” as used herein means C ₂ -C ₁₀ alkynyl and includes ethynyl, propynyl, butynyl, pentynyl and hexynyl groups. Unless otherwise specified, an alkynyl group is linear or branched, saturated or unsaturated, cyclic, acyclic or partially cyclic / noncyclic, unsubstituted, when a sufficient number of carbon atoms are present. Halo, cyano, nitro, OR ¹⁹ , OC (O) R ²⁰ , C (O) R ²¹ , C (O) OR ²² , NR ²³ R ²⁴ , C (O) NR ²⁵ R ²⁶ , SR ²⁹ , Optionally terminated by one or more substituents selected from C (O) SR ³⁰ , C (S) NR ²⁷ R ²⁸ , unsubstituted or substituted aryl, or unsubstituted or substituted Het (the R ¹⁹ to R ^30, the alkyl for is as defined above) may also be, and / or one or more (preferably less than 4) oxygen, sulfur, the silicon atom or, shea It may be interrupted by Bruno or dialkyl silicon groups or mixtures thereof.

  The terms “alkyl”, “aralkyl”, “alkaryl”, “arylene alkyl” and the like are interpreted to follow the previous definition of “alkyl” in the absence of the opposite information, as far as the alkyl or alk portion of the group is concerned. Should be.

  The preceding Ar or aryl groups can be linked by one or more covalent bonds, but references to “arylene” or “arylene alkyl” and the like are understood herein as two covalent linkages. Should be defined as Ar or aryl above as far as the arylene part of the group is concerned. References to “alkaryl”, “aralkyl” and the like should be construed as references to the preceding Ar or aryl as far as the Ar or aryl portion of the group is concerned.

Halo groups that can be substituted or terminated with the foregoing groups include fluoro, chloro, bromo and iodo.
The term “Het” as used herein includes 4 to 12 membered, preferably 4 to 10 membered ring systems, wherein the ring is selected from nitrogen, oxygen, sulfur and mixtures thereof. One or more heteroatoms, the ring does not contain any double bonds, or contains one or more double bonds, or is non-aromatic, partially aromatic Or it may be completely aromatic in nature. The ring system may be monocyclic, bicyclic, or fused. Each “Het” group identified herein may be unsubstituted or halo, cyano, nitro, oxo, alkyl (the alkyl group is itself unsubstituted as defined herein). -OR ¹⁹ , -OC (O) R ²⁰ , -C (O) R ²¹ , -C (O) OR ²² , -N ^{(R 23) R 24,} one selected from ^{-C (O) N (R 25} ) R 26, -SR 29, -C (O) SR 30 or ^{-C (S) N (R 27} ) R 28 Or optionally substituted by a plurality of substituents, R ^{19 to} R ³⁰ are independently hydrogen, unsubstituted or substituted aryl or alkyl (the alkyl group is itself unsubstituted, as defined herein) May be substituted, substituted, terminated Or in the case of R ²¹ represents halo, nitro, amino or cyano. Thus, the term “Het” refers to optionally substituted azetidinyl, pyrrolidinyl, imidazolyl, indolyl, furanyl, oxazolyl, isoxazolyl, oxadiazolyl, thiazolyl, thiadiazolyl, triazolyl, oxatriazolyl, thiatriazolyl, pyridazinyl, morpholinyl, pyrimidinyl, pyrazinyl , Quinolinyl, isoquinolinyl, piperidinyl, pyrazolyl and piperazinyl groups. Het substitutions can be made at a carbon atom of the Het ring or, where appropriate, at one or more of the heteroatoms.

A “Het” group may be in the form of an N oxide.
As mentioned herein, the term means nitrogen, oxygen, sulfur or mixtures thereof.

The adamantyl, congresyl, norbornyl or 1-norborndienyl group may optionally be in addition to a hydrogen atom, alkyl, —OR ¹⁹ , —OC (O) R ²⁰ , halo, nitro, —C (O) R. ²¹ , —C (O) OR ²² , cyano, aryl, —N (R ²³ ) R ²⁴ , —C (O) N (R ²⁵ ) R ²⁶ , —C (S) N (R ²⁷ ) R ²⁸ , — _{^{SR 29, -C (O) SR}} 30, -CF 3, -P (R 56) R 57, -PO (R 58) (R 59), - PO 3 H 2, -PO (OR 60) (OR 61 ) Or one or more substituents selected from —SO ₃ R ⁶² , wherein R ^{19 to} R ³⁰ , alkyl, halo, cyano and aryl are as defined herein, ^{56 to} R ⁶² independently represents hydrogen, alkyl, aryl or Het.

Suitably, if the adamantyl, congresyl, norbornyl or 1-norbornienyl group is substituted with one or more substituents as defined above, fairly preferred substituents include unsubstituted C ₁ -C ₈ Alkyl, —OR ¹⁹ , —OC (O) R ²⁰ , phenyl, —C (O) OR ²² , fluoro, —SO ₃ H, —N (R ²³ ) R ²⁴ , —P (R ⁵⁶ ) R ⁵⁷ , — C (O) N (R ²⁵ ) R ²⁶ and —PO (R ⁵⁸ ) (R ⁵⁹ ), —CF ₃ are included, R ¹⁹ represents hydrogen, unsubstituted C ₁ -C ₈ alkyl or phenyl, R ²⁰ , R ²² , R ²³ , R ²⁴ , R ²⁵ , R ²⁶ independently represent hydrogen or unsubstituted C ₁ -C ₈ alkyl, and R ⁵⁶ -R ⁵⁹ independently represent unsubstituted C ₁ -C Represents ₈ alkyl or phenyl. In one particularly preferred embodiment, the substituent is methyl, such as that found in C ₁ -C ₈ alkyl, more preferably 1,3 dimethyladamantyl.

Suitably, the adamantyl, congresyl, norbornyl or 1-norbornienyl group is in addition to a hydrogen atom a maximum of 10 substituents as defined above, preferably a maximum of 5 substituents as defined above, more preferably It can contain up to 3 substituents as defined above. Suitably, when an adamantyl, congresyl, norbornyl or 1-norbornienyl group contains one or more substituents as defined herein in addition to a hydrogen atom, preferably each substituent is the same . Preferred substituents are unsubstituted _C 1 -C ₈ alkyl and trifluoromethyl, particularly unsubstituted _C 1 -C ₈ alkyl such as methyl. A highly preferred adamantyl, congresyl, norbornyl or 1-norbornienyl group contains only hydrogen atoms, ie the adamantyl congresyl, norbornyl or 1-norbornienyl group is not substituted.

Preferably, when more than one adamantyl, congresyl, norbornyl or 1-norbornienyl group is present in a compound of formula I, each such group is the same.
^{2-Q 1} - tricyclo [3.3.1.1. {3,7}] decyl group (for convenience, the 2-meta-adamantyl group referred to hereinafter as Q ¹ where 2-meta-adamantyl is an arsenic, antimony or phosphorus atom, ie 2-arsa-adamantyl and / or 2-siba-adamantyl and / or 2-phospha-adamantyl, preferably called 2-phospha-adamantyl) may optionally contain one or more substituents in addition to the hydrogen atom. Suitable substituents include those defined herein for the adamantyl group. Highly preferred substituents include alkyl, especially unsubstituted C ₁ -C ₈ alkyl, especially methyl, trifluoromethyl, —OR ¹⁹ (R ¹⁹ is as defined herein), especially unsubstituted C ₁ -C a ₈ alkyl or aryl, and 4- dodecylphenyl. When the 2-meta-adamantyl group contains more than one substituent, preferably each substituent is the same.

Preferably, the 2-meta-adamantyl group is substituted at one or more of the 1, 3, 5 or 7 positions with a substituent as defined herein. More preferably, the 2-meta-adamantyl group is substituted at each of the 1, 3 and 5 positions. Suitably, such an arrangement means that the Q ¹ atom of the 2-meta-adamantyl group is bonded to a carbon atom of the adamantyl skeleton that does not have a hydrogen atom. Most preferably, the 2-meta-adamantyl group is substituted at each of the 1, 3, 5 or 7 positions. When the 2-meta-adamantyl group contains two or more substituents, preferably each substitution is the same. Particularly preferred substituents are unsubstituted C ₁ -C ₈ alkyl and haloalkyl, in particular unsubstituted C ₁ -C ₈ alkyl such as methyl and fluorinated C ₁ -C ₈ alkyl such as trifluoromethyl.

Preferably, the 2-meta - adamantyl, unsubstituted 2-meta - represents adamantyl, or a combination thereof, - adamantyl, or one or more unsubstituted C ₁ -C ₈ substituted with an alkyl substituent 2-meta.

  Preferably, the 2-meta-adamantyl group contains additional heteroatoms other than the 2-Q atom in the 2-meta-adamantyl skeleton. Suitable additional heteroatoms include oxygen and sulfur atoms, especially oxygen atoms. More preferably, the 2-meta-adamantyl group contains one or more additional heteroatoms at the 6, 9 and 10 positions. Even more preferably, the 2-meta-adamantyl group contains an additional heteroatom in each of the 6, 9 and 10 positions. Most preferably, when the 2-meta-adamantyl group contains two or more additional heteroatoms in the 2-meta-adamantyl skeleton, each of the additional heteroatoms is the same. Preferably, 2-meta-adamantyl contains one or more oxygen atoms in the 2-meta-adamantyl skeleton. Particularly preferred 2-meta-adamantyl groups are optionally substituted with one or more substituents as defined herein, and oxygen in each of the 6, 9 and 10 positions of the 2-meta-adamantyl skeleton. Contains atoms.

  Highly preferred 2-meta-adamantyl groups as defined herein include 2-phospha-1,3,5,7-tetramethyl-6,9,10-trioxoadamantyl, 2-phospha-1,3, 5-trimethyl-6,9,10-trioxoadamantyl, 2-phospha-1,3,5,7-tetra (trifluoromethyl) -6,9,10-trioxoadamantyl group and 2-phospha-1, 3,5-tri (trifluoromethyl) -6,9,10-trioxoadamantyl group is included. Most preferably, 2-phospha-adamantyl is 2-phospha-1,3,5,7-tetramethyl-6,9,10-trioxoadamantyl group or 2-phospha-1,3,5, -trimethyl- It is selected from 6,9,10-trioxoadamantyl group.

  The 2-meta-adamantyl group can be prepared by methods well known to those skilled in the art. Suitably, some 2-phospha-adamantyl compounds are available from Cytec Canada Inc. of Canada. Available from Similarly, the corresponding 2-meta-adamantyl compounds of formula I and the like can be obtained from the same supplier or can be prepared by similar methods.

Given the scope of the claims, preferred embodiments of the invention which are limited examples thereof include:
X ³ represents CR ⁷ (R ⁸ ) (R ⁹ ), X ⁴ represents CR ¹⁰ (R ¹¹ ) (R ¹² ), X ¹ represents CH (R ² ) (R ³ ), and X ² represents Represents CR ⁴ (R ⁵ ) H,
X ³ represents CR ⁷ (R ⁸ ) (R ⁹ ), X ⁴ represents CR ¹⁰ (R ¹¹ ) (R ¹² ), and X ¹ and X ² represent

Represents
X ³ represents CR ⁷ (R ⁸ ) (R ⁹ ), X ⁴ represents adamantyl, and X ¹ and X ² represent

Represents
X ³ represents CR ⁷ (R ⁸ ) (R ⁹ ), X ⁴ represents adamantyl, X ¹ represents CH (R ² ) (R ³ ), and X ² represents CR ⁴ (R ⁵ ) H. ,
X ³ represents CR ⁷ (R ⁸ ) (R ⁹ ), X ⁴ represents concresyl, X ¹ represents CH (R ² ) (R ³ ), and X ² represents CR ⁴ (R ⁵ ) H. ,
X ³ represents CR ⁷ (R ⁸ ) (R ⁹ ), X ⁴ represents concresyl, and X ¹ and X ² are

Represents
X ³ and X ⁴ independently represent adamantyl, and X ¹ and X ² are

Represents
X ³ and X ⁴ independently represent adamantyl, X ¹ represents CH (R ² ) (R ³ ), X ² represents CR ⁴ (R ⁵ ) H,
X ³ and X ⁴ together with Q ^{1 to} which they are attached can form a ring system of formula 1b;

X ¹ represents CH (R ² ) (R ³ ), X ² represents CR ⁴ (R ⁵ ) H,
X ³ and X ⁴ independently represent congressyl, and X ¹ and X ² are

Represents
X ³ and X ⁴ together with Q ^{1 to} which they are attached can form a ring system of formula 1b;

X ¹ and X ² are

Represents
X ³ and X ⁴ independently represent congresyl, X ¹ represents CH (R ² ) (R ³ ), X ² represents CR ⁴ (R ⁵ ) H,
X ³ and X ⁴ together with Q ^{1 to} which they are attached form a 2-phospha-adamantyl group, X ¹ represents CH (R ² ) (R ³ ), and X ² represents CR ⁴ ( It represents an R ⁵⁾ H,
X ³ and X ⁴ together with Q ^{1 to} which they are attached form a 2-phospha-adamantyl group, and X ¹ and X ² are

Is included.
A highly preferred embodiment of the present invention includes:
X ³ represents CR ⁷ (R ⁸ ) (R ⁹ ), X ⁴ represents CR ¹⁰ (R ¹¹ ) (R ¹² ), X ¹ represents CH (R ² ) (R ³ ), and X ² represents CH (R ⁴ ) (R ⁵ ), especially R ^{1 to} R ¹² are methyl,
X ³ represents CR ⁷ (R ⁸ ) (R ⁹ ), X ⁴ represents CR ¹⁰ (R ¹¹ ) (R ¹² ), and X ¹ and X ² represent

Is included.
Preferably, in the compound of formula I, X ³ is the same as X ⁴ and / or X ¹ is the same as X ² .

Particularly preferred combinations in the present invention include:
(1) X ³ represents CR ⁷ (R ⁸ ) (R ⁹ ), X ⁴ represents CR ¹⁰ (R ¹¹ ) (R ¹² ), and X ¹ and X ² represent

Represents
A and B are the same, -CH ₂ - represents,
Both Q ¹ and Q ² represent phosphorus bonded to the R group at the 1- or 2-position of the ring;
(2) X ³ represents CR ⁷ (R ⁸ ) (R ⁹ ), X ⁴ represents CR ¹⁰ (R ¹¹ ) (R ¹² ), X ¹ represents CH (R ² ) (R ³ ), X ² represents CH (R ⁴ ) (R ⁵ ),
A and B are the same, -CH ₂ - represents,
Both Q ¹ and Q ² represent phosphorus bonded to the R group at the 1- or 2-position of the ring;
(3) X ³ and X ⁴ together with Q ^{1 to} which they are attached form a 2-phospha-adamantyl group, wherein X ¹ and X ² are

Represents
A and B are the same, -CH ₂ - represents,
Both Q ¹ and Q ² represent phosphorus bonded to the R group at the 1- or 2-position of the ring;
(4) X ³ and X ⁴ represent adamantyl, and X ¹ and X ² are

Represents
A and B are the same, -CH ₂ - represents,
Included are those in which both Q ¹ and Q ² represent phosphorus bonded to the R group at the 1- or 2-position of the ring.

Preferably, in the previous embodiment, R ^{2 to} R ⁵ are methyl or ethyl.
Preferably, in the compound of formula I, A and B independently represent C ₁ -C ₆ alkylene, as optionally defined, eg, optionally substituted with an alkyl group. Preferably, the lower alkylene group represented by A and B is unsubstituted. A particularly preferred alkylene in which A and B can be independently represented is —CH ₂ — or —C ₂ H ₄ —. Most preferably, each of A and B represents the same alkylene as defined herein, in particular —CH ₂ —. Alternatively, one of A and B is deleted, ie Q ² or Q ¹ is directly attached to the group R and the other Q group is not directly attached to the group R, C ₁ -C _{It is 6} alkylene, preferably —CH ₂ — or —C ₂ H ₄ —, most preferably —CH ₂ —.

Even more preferred compounds of formula I include those wherein R ² -R ⁵ and R ⁷ -R ¹² are alkyl and are the same, preferably each representing C ₁ -C ₆ alkyl, especially methyl.

Among the particularly preferred specific compounds of formula I, each R ^{7 to} R ¹² is the same, represents methyl, A and B are the same, —CH ₂ — and R is benzene-1,2-diyl Is included.

  For clarity, references herein to Group 8, Group 9, or Group 10 metals include Groups 8, 9, and 10 in the current periodic table nomenclature. Should be interpreted. For the term “Group 8, Group 9 or Group 10”, metals such as Ru, Rh, Os, Ir, Pt and Pd are preferably selected. Preferably the metal is selected from Ru, Pt and Pd. More preferably, the metal is Pd.

Suitable compounds of such Group 8, 9 or 10 metals include such metals and nitric acid; sulfuric acid; lower alkane (up to C ₁₂ ) acids such as acetic acid and propionic acid; methanesulfonic acid, chlorosulfonic acid , Fluorosulfonic acid, trifluoromethanesulfonic acid, benzenesulfonic acid, naphthalenesulfonic acid, toluenesulfonic acid, sulfonic acids such as p-toluenesulfonic acid, t-butylsulfonic acid and 2-hydroxypropanesulfonic acid; sulfonated ion exchange Resins (including low acid concentration sulfone resins) Perhaloic acids such as perchloric acid; Halogenated carboxylic acids such as trichloroacetic acid and trifluoroacetic acid; Orthophosphoric acid; Phosphonic acids such as benzenephosphonic acid; and Lewis acids and Bronsted A salt with an acid obtained from the interaction between acids Includes compounds containing weakly coordinating anion derived from these acids. Other sources that can provide suitable anions include tetraphenylborate derivatives that are optionally halogenated, such as perfluorotetraphenylborate. Furthermore, zero-valent palladium complexes, in particular those with labile ligands, such as triphenylphosphine or alkenes such as dibenzylideneacetone or styrene or tri (dibenzylideneacetone) dipalladium can be used. The preceding anion can be introduced directly as a metal compound, but preferably independently a metal or metal compound catalyst system should be introduced.

  The anions are mostly in dilute aqueous solutions at 18 ° C., such as acids having a pKa of less than 6, more preferably less than 5, most preferably less than 4, salts with cations that do not interfere with the reaction, such as metal salts or alkylammonium. It can be obtained from or introduced as one or more of an organic salt and a precursor such as an ester that can be cleaved under reaction conditions to generate an anion in situ. Suitable acids and salts include the acids and salts listed above.

Particularly preferred acid promoters for alkoxycarbonylation are sulfonic acids including sulfonated ion exchange resins and the carboxylic acids listed above. The low concentration of the acid ion exchange resin that can be used preferably results in a concentration of SO ₃ H / Pd ratio of the reaction of less than 35 mol / mol, more preferably less than 25 mol / mol, and most preferably less than 15 mol / mol in the reaction. General range of SO ₃ H concentration provided by the resin, 1~40mol / mol of Pd, more typically of from 2 to 30 mol / mol Pd, the range of most commonly the 3~20mol / mol Pd It is.

  In general, anion (s) suitable for the reaction can be selected. Some ethylenically unsaturated compounds are more sensitive to the pKa of the anionic acid than others, and conditions and solvents can be varied appropriately within the purview of those skilled in the art. For example, in butadiene carbonylation, the pKa of the anionic acid should exceed 2 in dilute aqueous solution at 18 ° C., and more preferably has a pka between 2 and 5.

In the carbonylation reaction, the amount of anion present is not critical to the catalytic behavior of the catalyst system. The molar ratio of the anion to the Group 8, 9 or 10 metal or compound is 1: 1 to 10000: 1, preferably 10: 1 to 2000: 1, in particular 100: 1 to 1000: 1. Good. Where the anion is provided by an acid and salt, the relative proportion of acid and salt is not critical. However, if the anion is provided by an acid or partially provided by an acid, the ratio of acid to the Group 8, 9 or 10 metal is preferably the same ratio as the anion to the metal or the previous compound. It is. H ⁺ is an activity such that 1 mol of monobasic acid has 1 mol of H ⁺ , 1 mol of dibasic acid has 2 mol of H ⁺ , tribasic acid etc. is interpreted accordingly. Means the amount of acidic sites. Similarly C ²⁺ is meant moles of metal having a 2 ⁺ cationic charge, the ratio of the metal cation for M ⁺ ions should therefore be adjusted accordingly. For example, an M ⁺ cation should be interpreted as having 0.5 moles of C ²⁺ per mole of M ⁺ .

In the alkoxycarbonylation reaction, preferably the ratio of bidentate ligand to acid is at least 1: 2 mol / mol (H ⁺ ), preferably bidentate ligand and group 8, 9 or group. The ratio of Group 10 metal is at least 1: 1 mol / mol (C ²⁺ ). Preferably, the ligand exceeds the metal mol / mol (C ²⁺ ), preferably the ratio to the acid exceeds 1: 2 mol / mol (H ⁺ ). An excess of ligand is advantageous because the ligand itself can act as a base to buffer the acid concentration in the reaction and prevent degradation of the substrate. On the other hand, the presence of acid activates the reaction mixture and improves the overall rate of reaction.

In the hydroxycarbonylation reaction, preferably the ratio of bidentate ligand to acid is at least 1: 2 mol / mol (H ⁺ ), preferably bidentate ligand and group 8, 9 or group. The ratio of Group 10 metal is at least 1: 1 mol / mol (C ²⁺ ). Preferably, the ligand exceeds the metal mol / mol (C ²⁺ ). Excess ligand can be advantageous because the ligand itself can act as a base to buffer the acid concentration in the reaction and prevent degradation of the substrate. On the other hand, the presence of acid activates the reaction mixture and improves the overall rate of reaction.

As mentioned, the catalyst system of the present invention can be used in a homogeneous system or in a heterogeneous system. Preferably, the catalyst system is used in a homogeneous system.
Suitably, the process of the present invention can be used to catalyze the carbonylation of ethylenically unsaturated compounds in the presence of carbon monoxide and hydroxyl group containing compounds and optionally an anion source. The ligands of the present invention lead to surprisingly high TONs in carbonylations such as ethylene, propylene, 1,3-butadiene, pentenenitrile and octene carbonylation. As a result, the commercialization of the carbonylation process will be increased by using the process of the present invention.

  Advantageously, the use of the catalyst system of the present invention, such as in the carbonylation of ethylenically unsaturated compounds, also provides a good rate, especially for alkoxycarbonylation and hydroxycarbonylation.

  The process of the present invention may be a batch process or a continuous process. However, in aging tests on the ligands of the present invention, it was found that the ligands are surprisingly resistant to decay and remain active after several reuses. The method according to the invention is therefore particularly suitable for continuous processes.

  Given the claims, references herein to ethylenically unsaturated compounds include any one of the compounds, including those found in alkenes, alkynes, conjugated and unconjugated dienes, functional alkenes, and the like. It should be construed as containing one or more unsaturated C—C bond (s).

  Suitable ethylenically unsaturated compounds for the present invention are ethylenically unsaturated compounds having 2 to 50 carbon atoms per molecule or mixtures thereof. Suitable ethylenically unsaturated compounds can have one or more isolated or conjugated unsaturated bonds per molecule. Preferred are compounds having from 2 to 20 carbon atoms or mixtures thereof, more preferred are compounds having up to 18 carbon atoms, even more preferably up to 16 carbon atoms, and Further preferred compounds have a maximum of 10 carbon atoms. In a preferred group of processes, the ethylenically unsaturated compound is an olefin or a mixture of olefins. Suitable ethylenically unsaturated compounds include alkyl pentenoates such as acetylene, methyl acetylene, propyl acetylene, 1,3-butadiene, ethylene, propylene, butylene, isobutylene, pentene, pentenenitrile, methyl 3-pentenoate. Pentenoic acid (such as 2- and 3-pentenoic acid), heptene, octene, dodecene.

  Particularly preferred ethylenically unsaturated compounds are ethylene, 1,3-butadiene, alkylpentenoate, pentenenitrile, pentenoic acid (such as 3-pentenoic acid), acetylene, heptene, butylene, octene, dodecene and propylene.

Particularly preferred ethylenically unsaturated compounds are ethylene, propylene, heptene, octene, dodecene, 1,3-butadiene and pentenenitrile.
Still further, it is possible to carbonylate a mixture of alkenes containing branched alkenes containing internal double bonds and / or saturated hydrocarbons. Examples include raffinate 1, raffinate 2, and other mixed streams obtained from crackers, or mixed streams obtained from alkene dimerization (butene dimerization is one example) and Fischer-Tropsch reactions. is there.

References herein to ethylenically unsaturated compounds exclude vinyl esters including vinyl acetate and other functionalized alkenes.
Where a compound of the formula herein (eg, Formula I) contains an alkenyl group or cycloalkyl moiety as defined, cis (E) and trans (Z) isomerism may also occur. The present invention includes the individual stereoisomers of compounds of any of the formulas defined herein, as well as the individual tautomers, where appropriate, together with mixtures thereof. Separation of stereoisomers or cis and trans isomers can be accomplished by conventional techniques, for example, fractional crystallization, chromatography or H.264 of a mixture of stereoisomers of one compound of the formula or its appropriate salt or derivative. P. L. C. Can be achieved. Individual enantiomers of one compound of the formula can be prepared from the corresponding optically pure intermediate, or the corresponding racemic H. using the appropriate chiral support. P. L. C. Or, where appropriate, by resolution, such as by fractional crystallization of stereoisomeric salts formed by reaction of the corresponding racemate with the appropriate optically active acid or base.

All stereoisomers are included within the scope of the process of the invention.
One skilled in the art can function as a ligand for a compound of formula (I) to coordinate with a Group 8, 9 or 10 metal or compound thereof to form a compound for use in the present invention. Will be understood. In general, the Group 8, 9 or 10 metal or compound thereof is coordinated to one or more phosphorus, arsenic and / or antimony atoms of the compound of formula (I).

  As stated above, the present invention enumerates above, comprising contacting an ethylenically unsaturated compound with a source of hydroxyl groups such as carbon monoxide and water or alkanol in the presence of a catalyst compound as defined in the present invention. A method for the carbonylation of ethylenically unsaturated compounds such as

Suitably, the source of hydroxyl groups comprises organic molecules having hydroxyl functionality. Preferably, the organic molecule having a hydroxyl functional group may be branched or linear and includes C ₁ -C ₃₀ alkanols including alkanols, especially aryl alkanols, which are alkyl, aryl, as defined herein. Het, halo, cyano, nitro, OR ¹⁹ , OC (O) R ²⁰ , C (O) R ²¹ , C (O) OR ²² , NR ²³ R ²⁴ , C (O) NR ²⁵ R ²⁶ , C (S) It may be optionally substituted with one or more substituents selected from NR ²⁷ R ²⁸ , SR ²⁹ or C (O) SR ³⁰ . Highly preferred alkanols are C ₁ -C ₈ alkanols such as methanol, ethanol, propanol, iso-propanol, iso-butanol, t-butyl alcohol, n-butanol, phenol and chlorocapryl alcohol. Monoalkanols are most preferred, but polyalkanols preferably selected from di-octols such as diols, triols, tetraols and sugars can also be utilized. In general, such polyalkanols are 1,2-ethanediol, 1,3-propanediol, glycerol, 1,2,4 butanetriol, 2- (hydroxymethyl) -1,3-propanediol, 1,2,6. Selected from trihydroxyhexane, pentaerythritol, 1,1,1 tri (hydroxymethyl) ethane, nanose, sorbase, galactose and other sugars. Preferred saccharides include sucrose, fructose and glucose. Particularly preferred alkanols are methanol and ethanol. The most preferred alkanol is methanol.

  The amount of alcohol is not important. Generally, an amount exceeding the amount of substrate to be carbonylated is used. Thus, the alcohol can act as a reaction solvent as well, but a separate solvent can be used if desired.

It will be appreciated that the final product of the reaction will be determined at least in part by the source of alkanol used. For example, when methanol is used, the corresponding methyl ester is produced. Conversely, the use of water produces the corresponding acid. Accordingly, the present invention provides a convenient method of adding a radical _{-C (O)} OC 1 ~C ₃₀ alkyl or aryl or -C (O) OH via an ethylenically unsaturated bond.

  In the process of the present invention, carbon monoxide can be used in pure form or diluted with an inert gas such as a noble gas such as nitrogen, carbon dioxide or argon. A small amount of hydrogen, generally less than 5% by volume, may also be present.

  The ratio (volume / volume) of ethylenically unsaturated compound to hydroxyl group source in the liquid phase reaction medium can vary widely, but is suitably in the range 1: 0.1 to 1:10, preferably 2 : Between 1 and 1: 2, and if the alkanol or water is also the reaction solvent, up to a large excess of alkanol or water, such as a maximum of 100: 1 excess alkanol or water. However, when the ethylenically unsaturated compound is a gas at the reaction temperature, 1: 20,000-1: 10, more preferably 1: 10,000-1: 50, most preferably 1: 5000-1: 500, etc. Can be present at low concentrations in the liquid phase reaction medium at a ratio to the source of hydroxyl groups.

The amount of the catalyst of the present invention used in the carbonylation process is not critical. Good results indicate that preferably the amount of Group 8, 9 or 10 metal is 10 ⁻⁷ to 10 ⁻¹ mole per mole of ethylenically unsaturated compound in the liquid phase carbonylation reaction medium, more preferably Is obtained in the range of 10 ⁻⁶ to 10 ⁻² mol, most preferably 10 ⁻⁵ to 10 ⁻² mol.

  Although not essential to the present invention, suitably the carbonylation of the ethylenically unsaturated compound as defined herein can be carried out in one or more aprotic solvents. Suitable solvents include, for example, ketones such as methyl butyl ketone; such as anisole (methyl phenyl ether), 2,5,8-trioxanonane (diglyme), diethyl ether, dimethyl ether, tetrahydrofuran, diphenyl ether, diisopropyl ether and dimethyl ether of diethylene glycol. Ethers; for example, methyl acetate, dimethyl adipate, esters such as methyl benzoate, dimethyl phthalate and butyrolactone; amides such as dimethylacetamide, N-methylpyrrolidone and dimethylformamide; -2,2-dioxide), 2-methylsulfolane, diethylsulfone, tetrahydrothiophene Sulfoxides and sulfones such as 1,2-dioxide and 2-methyl-4-ethylsulfolane; for example, benzene, toluene, ethylbenzene, o-xylene, m-xylene, p-xylene, chlorobenzene, o-dichlorobenzene, m-dichlorobenzene, etc. Aromatic compounds containing halo variants of the compounds; alkanes containing halo variants of compounds such as hexane, heptane, 2,2,3-trimethylpentane, methylene chloride and carbon tetrachloride; eg benzonitrile and acetonitrile Nitrile is included.

Very suitable are aprotic solvents having a dielectric constant in 298.15 K and 1 × 10 ⁵ Nm ⁻² of values less than 50, more preferably in the range of 3-8. In the context of the present invention, the dielectric constant for a given solvent is used in its usual sense to represent the ratio of the capacitor capacity for that material as a dielectric to the same capacitor capacity of the dielectric in vacuum. The value of the dielectric constant of a normal organic liquid is David R. Can be found in general references such as Handbook of Chemistry and Physics, edition 76, edited by Lide et al., CRC published in 1995, usually about 20 ° C. or 25 ° C., ie about 293.15 K or 298. It can be easily converted to its temperature and pressure using a conversion factor estimated or estimated for ¹⁵ K and atmospheric pressure, ie about 1 × 10 ⁵ Nm ⁻² . If literature data is not available for a particular compound, the dielectric constant can be readily measured using established physicochemical methods.

  For example, anisole has a dielectric constant of 4.3 (at 294.2K), diethyl ether is 4.3 (at 293.2K), sulfolane is 43.4 (at 303.2K), and methyl pentanoate Is 5.0 (at 293.2K), diphenyl ether is 3.7 (at 283.2K), dimethyl adipate is 6.8 (at 293.2K), and tetrahydrofuran is 7.5 (295). At 2K) and methyl nonanoate is 3.9 (at 293.2K). A preferred aprotic solvent is anisole.

  In the presence of alkanol, if the ethylenically unsaturated compound, carbon monoxide, and the ester carbonylation product of alkanol are aprotic solvents, the aprotic solvent will be produced by the reaction.

  The process can be carried out in excess aprotic solvent, ie at a ratio of at least 1: 1 aprotic solvent to alkanol (v / v). Preferably, this ratio ranges from 1: 1 to 10: 1, more preferably from 1: 1 to 5: 1. Most preferably, this ratio (v / v) ranges from 1.5: 1 to 3: 1.

  In spite of the foregoing, the reaction is preferably carried out in the absence of any aprotic solvent added externally, that is, in the absence of an aprotic solvent that is not produced by the reaction itself.

  During the hydroxycarbonylation, the presence of a protic solvent is also preferred. Protic solvents can include carboxylic acids or alcohols. Mixtures of aprotic and protic solvents can also be used.

  Hydrogen can be added to the carbonylation reactant to improve the reaction rate. When used, suitable concentrations of hydrogen are between 0.1 and 20% vol / vol for carbon monoxide, more preferably 1-20% vol / vol for carbon monoxide, more preferably It may be a ratio of 2-15% vol / vol to carbon monoxide, most preferably 3-10% vol / vol to carbon monoxide.

The catalyst compounds of the present invention can act as “heterogeneous” or “homogeneous” catalysts, preferably homogeneous catalysts.
The term “homogeneous” catalyst is preferably unsupported in the appropriate solvents described herein, except that the reactants of the carbonylation reaction (eg, ethylenically unsaturated compounds, hydroxyl-containing compounds and monoxides). Means a catalyst which is simply mixed with or formed in situ, i.e. a compound of the invention.

The term “heterogeneous” catalyst means a catalyst supported on a support, ie a compound of the invention.
Thus, according to a further aspect, the present invention provides a method for the carbonylation of an ethylenically unsaturated compound as defined herein, which method uses a catalyst comprising a support, preferably an insoluble support. Implemented.

  Preferably, the support is a polymer, eg, a polystyrene copolymer such as a polyolefin, polystyrene or divinylbenzene copolymer, or other suitable polymer or copolymer known to those skilled in the art; a silicon derivative such as functionalized silica, silicone or silicone rubber; or Other porous particulate materials such as inorganic oxides and inorganic chlorides are included.

Preferably, the support material is a porous silica having a surface area in the range of 10 to 700 m ² / g, a total pore volume in the range of 0.1 to 4.0 cc / g and an average particle size in the range of 10 to 500 μm. is there. More preferably, the surface area is in the range of 50 to 500 m ² / g, the pore volume is in the range of 0.5 to 2.5 cc / g, and the average particle size is in the range of 20 to 200 μm. Most desirably, the surface area is in the range of 100 to 400 m ² / g, the pore volume is in the range of 0.8 to 3.0 cc / g, and the average particle size is in the range of 30 to 100 μm. The average particle size of a general porous support material is in the range of 10 to 1000 mm. A support material having an average pore diameter of preferably 50 to 500 mm, most desirably 75 to 350 mm is used. It is particularly desirable to dehydrate the silica at a temperature of 100 ° C. to 800 ° C. for 3 to 24 hours.

  Suitably the support may be a flexible support or a rigid support, the insoluble support is coated with a compound of the method of the invention by techniques well known to those skilled in the art, and / or Impregnate it.

  Alternatively, the compound of the method of the invention is optionally immobilized on the surface of the insoluble support via a covalent bond, and the sequence optionally contains a bifunctional spacer molecule for spacing from the insoluble support to the compound. Including.

  The compounds of the present invention can be used to react functional groups present in compounds of formula I, such as substituents of an aromatic structure, using complementary reactive groups present on the support or previously inserted into the support. By promoting, it can be fixed on the surface of the insoluble support. The combination of the reactive group of the support and the complementary substituent of the compound of the present invention results in the heterogeneity in which the compound of the present invention and the support are bonded via a bond such as an ether, ester, amide, amine, urea, or keto group. A system catalyst is provided.

  The choice of reaction conditions for binding the compound of the process of the invention to the support depends on the ethylenically unsaturated compound and the support group. For example, reagents such as carbodiimide, 1,1'-carbonyldiimidazole, as well as the use of mixed anhydrides, methods such as reductive amination can be used.

According to a further aspect, the present invention provides the use of the method or ligand catalyst composition of any aspect of the present invention wherein the catalyst is bound to a support.
Furthermore, the bidentate phosphine can be bound to a suitable polymer substrate via at least one of the bridging substituent, bridging group R, linking group A or linking group B, preferably 3, 5 or 6 of the benzene group. It can be bonded to polystyrene via a single ring carbon to provide a fixed heterogeneous catalyst.

  The amount of bidentate ligand that can be used can vary widely. Preferably, the bidentate ligand has a ratio of the number of moles of bidentate ligand present to the number of moles of Group 8, Group 9 or Group 10 metal present between 1 and 50 per mole of metal. It is present in an amount such that it is a mole, for example 1-15 moles, in particular 1-10 moles. More preferably, the molar: molar range of the compound of formula I and the Group 8, 9 or 10 metal is in the range of 1: 1 to 20: 1, most preferably 1: 1 to 10: 1, or Further, the range is from 1: 1 to 1.5: 1. Conveniently, these low molar ratios are applicable, thereby avoiding the use of excess compounds of formula I and thus minimizing the consumption of these normally expensive compounds. It is advantageous. Suitably, the catalyst of the present invention is prepared in a separate step prior to its use in situ in the carbonylation reaction.

  Conveniently, the process of the present invention comprises a Group 8, 9 or 10 metal or a compound thereof as defined herein in a suitable solvent (such as one of the aforementioned alkanols or aprotic solvents ( A particularly preferred solvent is carried out by dissolving in the ester or acid product of a particular carbonylation reaction, such as methyl propionate of ethylene carbonylation, and then mixing with a compound of formula I as defined herein. obtain.

Carbon monoxide can be used in the presence of other gases that are inert in the reaction. Examples of such gases include noble gases such as hydrogen, nitrogen, carbon dioxide and argon.
The product of the reaction can be separated from the other components by any suitable means. However, it is an advantage of this method that significantly less by-products are formed, as evidenced by generally significantly higher selectivity, thereby reducing the need for further purification after the initial separation of the product. A further advantage is that other components containing the catalyst system can be reused and / or reused in further reactions to minimize the replenishment of new catalyst.

  Preferably, the carbonylation is carried out at a temperature between -30 and 170 ° C, more preferably between -10 and 160 ° C, most preferably between 20 and 150 ° C. A particularly preferred temperature is a temperature selected between 40 ° C and 150 ° C. Advantageously, the carbonylation can be carried out at a moderate temperature, in particular the reaction can be carried out at room temperature (20 ° C.).

  Preferably, when performing low temperature carbonylation, the carbonylation is between -30 ° C and 49 ° C, more preferably between -10 ° C and 45 ° C, even more preferably between 0 ° C and 45 ° C, most preferably between 10 ° C and 45 ° C. Between. Particularly preferred is a range of 10 to 35 ° C.

Preferably, the carbonylation is 0.80 × 10 ⁵ N.I. m ^{−2 to} 90 × 10 ⁵ N.I. m ⁻² , more preferably 1 × 10 ⁵ N.m. m ^{−2 to} 65 × 10 ⁵ N.I. m ⁻² , most preferably 1-50 × 10 ⁵ N.m. ^Performed with CO partial pressure between m- ² . Particularly preferred is 5-45 × 10 ⁵ N.P. It is the CO partial pressure of m- ² .

Preferably low pressure carbonylation is also envisaged. Preferably, when low pressure carbonylation is performed, the carbonylation is 0.1-5 × 10 ⁵ N.I. m ⁻² , more preferably 0.2 to 2 × 10 ⁵ N.m. m ⁻² , most preferably 0.5 to 1.5 × 10 ⁵ N.m. ^Performed with CO partial pressure between m- ² .

  There is no particular limitation on the duration of the carbonylation unless carbonylation within a commercially acceptable time scale is clearly preferred. The carbonylation of the batch reaction can be performed for up to 48 hours, more typically up to 24 hours, and most typically up to 12 hours. In general, the carbonylation takes at least 5 minutes, more usually at least 30 minutes, more typically at least 1 hour. For continuous reactions, such time scale is clearly irrelevant and the continuous reaction can continue until it requires catalyst replenishment, as long as TON is commercially acceptable.

The catalyst system of the present invention is preferably configured in a liquid phase that can be formed by one or more of the reactants or by the use of a suitable solvent.
The use of a stabilizing compound with the catalyst system can also be beneficial in improving the recovery of metal lost from the catalyst system. If the catalyst system is utilized in a liquid reaction medium, such stabilizing compounds can aid in the recovery of the Group 8, 9 or 10 metal.

  Thus, preferably, the catalyst system comprises a polymer dispersant dissolved in a liquid support in a liquid reaction medium, said polymer dispersant being in the liquid support a Group 8, 9 or 10 metal or A colloidal suspension of metal compound particles can be stabilized.

  The liquid reaction medium may be a solvent for the reaction or may include one or more of the reactants or reaction products themselves. The liquid form of the reactants and reaction products may be miscible or dissolved in the solvent or liquid diluent.

  The polymeric dispersant is soluble in the liquid reaction medium, but should not significantly increase the viscosity of the reaction medium in a manner that is detrimental to reaction rate or heat transfer. The solubility of the dispersant in the reaction medium under temperature and pressure reaction conditions should not be so high as to significantly prevent the adsorption of dispersant molecules onto the metal particles.

  The polymer dispersant stabilizes the colloidal suspension of the Group 8, 9 or 10 metal or metal compound particles in the liquid reaction medium and thus liquids the metal particles formed as a result of catalyst degradation. It can be kept in suspension in the reaction medium and discharged from the reactor together with the liquid for regeneration and possibly reuse in the production of further amounts of catalyst. Metal particles can in some cases form larger particles, but are usually in the colloidal dimensions, for example in the range of an average particle size of 5-100 nm. A portion of the polymer dispersant adsorbs on the surface of the metal particles, while the rest of the dispersant molecules remain at least partially solvated by the liquid reaction medium, and thus dispersed Group 8, Group 9 or Group 10 metal particles do not deposit in dead space on or in the reactor walls, and do not form aggregates of metal particles that grow due to particle collision and eventually solidify. Stabilize. Some agglomeration of the particles can occur even in the presence of a suitable dispersant, but when the type and concentration of the dispersant is optimized, such agglomeration will be at a relatively low level and the agglomerates will only fall apart. It is not formed and therefore agglomerates can be broken by stirring and the particles can be redispersed.

The polymeric dispersant can include homopolymers or copolymers including polymers such as graft copolymers and star copolymers.
Preferably, the polymeric dispersant has sufficient acidic or basic functionality to substantially stabilize the colloidal suspension of said Group 8, 9 or 10 metal or metal compound. .

Substantially stabilized means that precipitation of Group 8, 9 or 10 metal from the liquid phase is substantially avoided.
Particularly preferred dispersants for this purpose include acidic or basic polymers including carboxylic acids such as polyacrylates, sulfonic acids, amines and amides, or substituted polyvinyl polymers such as heterocycles, especially nitrogen heterocycles, polyvinylpyrrolidone, or The aforementioned copolymers are included.

  Examples of such polymer dispersants are polyvinylpyrrolidone, polyacrylamide, polyacrylonitrile, polyethyleneimine, polyglycine, polyacrylic acid, polymethacrylic acid, poly (3-hydroxybutyric acid), poly-L-leucine, poly-L-methionine. , Poly-L-proline, poly-L-serine, poly-L-tyrosine, poly (vinylbenzene sulfonic acid) and poly (vinyl sulfonic acid), acylated polyethyleneimine. Suitable acylated polyethylenimines are described in the BASF patent application EP 1330309A1 and US Pat. No. 6,723,882.

Preferably, the polymeric dispersant incorporates an acidic or basic moiety that is pendant or within the polymer backbone. Preferably, the acidic moiety has a dissociation constant (pK _a ) of less than 6.0, more preferably less than 5.0, and most preferably less than 4.5. Preferably, the basic moiety has a base dissociation constant (pK _b ) of less than 6.0, more preferably less than 5.0, and most preferably less than 4.5, and pK _a and pK _b are in a dilute aqueous solution. Measured at 25 ° C.

Suitable polymeric dispersants, in addition to being soluble in the reaction medium at the reaction conditions, contain at least one acidic or basic moiety that is in the polymer backbone or as a pendant group. The inventors have found that polymers incorporating acid and amide moieties such as polyacrylates such as polyvinylpyrrolidone (PVP) and polyacrylic acid (PAA) are particularly suitable. The molecular weight of a polymer suitable for use in the present invention depends on the nature of the reaction medium and the solubility of the polymer in the reaction medium. The inventors have found that the average molecular weight is usually less than 100,000. Preferably, the average molecular weight ranges from 1,000 to 200,000, more preferably from 5,000 to 100,000, most preferably from 10,000 to 40,000, for example when using PVP, M _w is The range is preferably 10,000 to 80,000, more preferably 20,000 to 60,000. In the case of PAA, it is about 1,000 to 10,000.

The effective concentration of dispersant in the reaction medium should be determined for each reaction / catalyst system used.
The dispersed Group 8, 9 or 10 metal is recovered from the liquid stream withdrawn from the reactor, for example by filtration, and then discarded or reused as a catalyst or for other applications. Can be processed. In a continuous process, the liquid stream can be circulated through an external heat exchanger, and in such cases, a filter for palladium particles can be conveniently installed in these circulation devices.

  Preferably the polymer: metal mass ratio g / g is between 1: 1 and 1000: 1, more preferably between 1: 1 and 400: 1, most preferably between 1: 1 and 200: 1. is there. Preferably, the polymer: metal mass ratio g / g is at most 1000, more preferably at most 400 and most preferably at most 200.

  Any of the features described in the first aspect of the invention can be considered as preferred features of the second, third, fourth, fifth and other aspects of the invention, and vice versa. It will be understood.

The present invention extends not only to novel bidentate ligands of formula (I), but also to novel complexes of such ligands with Group 8, 9 or 10 metals or compounds thereof.
The invention will now be illustrated and illustrated by the following non-limiting examples and comparative examples.

PREPARATIVE EXAMPLE Preparation of 1,2-benzenedimethanol cyclic sulfate (3) The method used for the synthesis of the phosphine ligands of the derivatives of the examples starts with the synthesis of cyclic sulfate (3). The cyclic sulfate compound (3) is formed by the synthesis of two steps. A commercially available di-alcohol 1,2-benzenedimethanol (1) (which can also be prepared by lithium aluminum hydroxide reduction of phthalic acid) is reacted with thionyl chloride (SOCl ₂ ) in dichloromethane to give a cyclic sulfite complex ( 2) was obtained. Next, the cyclic sulfite complex was oxidized with sodium periodate and ruthenium trichloride to obtain a cyclic sulfate complex (3).

Preparation of 1- (di-tert-butylphosphinomethane) -2- (diphenylphosphinomethane) benzene (7) Mixed phosphine (7) was prepared in a two-step process. A cyclic sulfuric acid ^ester, _Bu t 2 PH. It was reacted with a lithium salt of BH ₃ (4), and then continuously reacted with a lithium salt of Ph ₂ PH (5). The boron protected phosphine (6) is then deboronated by adding tetrafluoroboric acid and then the bis-phosphonium salt prepared in situ is reduced to the free phosphine (7) by adding potassium hydroxide. did. The other three mixed phosphines were prepared as in (7).

Experimental Overview Unless otherwise indicated, all manipulations were performed under a nitrogen atmosphere using standard Schlenk tube, cannula and glove box techniques. All NMR experiments were performed using CDCl ₃ as the solvent.

Preparation of cyclic sulfate (3) Dialcohol (1) (21.2 g, 153 mmol) was partially dissolved in dichloromethane (250 ml). To this was slowly added thionyl chloride (13.8 ml, 189 mmol). This generated a large amount of gas. The resulting solution was then heated to reflux (50 ° C.) for 90 minutes. The resulting solution was then cooled to room temperature and stirred overnight. At this point, the cyclic sulfite complex (2) was formed. The solvent was then removed under vacuum to give a light brown oil. The cyclic sulfite was then diluted with dichloromethane (100 ml), acetonitrile (100 ml) and water (150 ml). To the resulting dibasic solution was added sodium periodate (65.3 g, 306 mmol) and ruthenium trichloride hydrate (300 mg). The resulting suspension was then stirred at room temperature for 1 hour during which a large amount of white precipitate formed. The final suspension was diluted with water (100 ml) and ether (100 ml) was added. The organic layer was collected by separation and the aqueous residue was washed with ether (2 × 100 ml). The combined organic extract was then washed with water (2 × 200 ml) and then dried over sodium sulfate. The organic extract was then filtered through celite-containing filter paper. This gave a colorless solution. The solvent was then removed under vacuum to give an off-white solid. The solid was stored in a -20 ° C freezer. Yield = 24.6 g, 80%. ¹ H NMR (500 MHz, CDCl ₃ , δ), 7.46 (m, 2H, Ph), 7.38 (m, 2H, Ph), 5.44 (s, 4H, CH ₂ ) ppm.

Preparation of di-tert-butylphosphine borane (4) Di-tert-butylphosphine chloride (34 g, 188.41 mmol) was placed in a Schlenk flask followed by addition of diethyl ether (200 ml). The ether solution was cooled in a cold water bath and LiAlH ₄ (1M in diethyl ether, 100 ml, 100 mmol) was added slowly. This gave a yellow suspension that was stirred overnight at room temperature. The suspension was quenched by the addition of water (50 ml, degassed with nitrogen for 20 minutes). This gave a dibasic solution. The upper layer (organic layer) was cannula transferred to a clean Schlenk and the aqueous residue was washed with an additional 100 ml of ether. The ether extracts were mixed and dried over sodium sulfate. The ether extract was then cannula transferred to a clean Schlenk and the ether removed by distillation. This gave a colorless oil. The colorless oil was then diluted with THF (200 ml) and cooled to 0 ° C., to which was added BH ₃ in THF (1M solution, 250 ml, 250 mmol). The resulting solution was then stirred overnight at room temperature. The solvent was then removed under vacuum to give a white crystalline solid that was then isolated in a glove box. Yield = 22.1 g, 73% yield. ³¹ P { ¹ H} NMR (80 MHz, CDCl ₃ , δ): δ 49.23 ppm (multiple line).

Preparation of diphenylphosphine (5) Diphenylchlorophosphine (34.8 ml, 188.41 mmol) was placed in a Schlenk flask followed by addition of diethyl ether (200 ml). The ether solution was cooled in a cold water bath and LiAlH ₄ (1M in diethyl ether, 100 ml, 100 mmol) was added slowly. This gave a yellow suspension that was stirred overnight at room temperature. The suspension was quenched by the addition of HCl (concentrated, 20 ml) in water (40 ml, degassed with nitrogen for 20 minutes). This gave a dibasic solution. The upper layer (organic layer) was cannula transferred to a clean Schlenk and the aqueous residue was washed with an additional 100 ml of ether. The ether extracts were mixed and dried over sodium sulfate. The ether extract was then dried under vacuum. This gave a pale yellow oil, yield = 36 g. The phosphine was stored in a freezer. ³¹ P { ¹ H} NMR (161.9 MHz, CDCl ₃ , δ): −37.9 ppm
NB. Diphenylphosphine has a low boiling point and is highly heat sensitive and should be stored in a freezer. As a modification of this procedure, the ether should be removed under vacuum rather than distillation due to the high boiling point of phosphine.

Preparation of di-tert-butylphosphine (5b) Di-tert-butylphosphine chloride (34 g, 188.41 mmol) was placed in a Schlenk flask followed by addition of diethyl ether (200 ml). The ether solution was cooled in a cold water bath and LiAlH ₄ (1M in diethyl ether, 100 ml, 100 mmol) was added slowly. This gave a yellow suspension that was stirred overnight at room temperature. The suspension was quenched with water (50 ml, degassed with nitrogen for 20 minutes). This gave a dibasic solution. The upper layer (organic layer) was cannula transferred to a clean Schlenk and the aqueous residue was washed with an additional 100 ml of ether. The ether extracts were mixed and dried over sodium sulfate. The ether extract was then cannula transferred to a clean Schlenk and the ether removed by distillation. This gave a colorless oil. Yield = 22.0 g, 80%. ³¹ P { ¹ H} NMR (161.9 MHz, CDCl ₃ ): δ 21.0 ppm
Preparation of 1- (di -tert- butylphosphino {borane} methyl) -2- (diphenylphosphino) benzene (6) Bu ^t ₂ PH. BH ₃ (4) (9.68 g, 60.50 mmol) was dissolved in THF (70 ml), and Bu ⁿ Li (2.5 M in hexane, 28.6 ml, 71.39 mmol) was added thereto. The resulting yellow solution was stirred for 1 hour. Cyclic sulfate (3) (11.0 g, 55.0 mmol) was dissolved in THF (100 ml) and cooled to -78 ° C. The lithium phosphide solution was then added dropwise to the cyclic sulfate solution. After the addition was complete, the resulting solution was stirred at −78 ° C. for 30 minutes and then warmed to room temperature. The solution was then stirred for 3 hours at room temperature. The solution was then cooled to -78 ° C.

Diphenylphosphine (5) (85% purity, 11.05 ml, 60.0 mmol by decomposition) was diluted with THF (70 ml). This ^Bu n Li (hexanes 2.5M, 26.4ml, 65.95mmol) was added. The resulting red solution was then added dropwise to the cyclic sulfate solution at −78 ° C. After the addition was complete, the solution was stirred at −78 ° C. for 30 minutes, then warmed to room temperature and then stirred overnight. The solvent was then removed under vacuum to give a yellow solid / gel. Ether (250 ml) was then added followed by water (100 ml, degassed with nitrogen for 30 minutes). This gave a dibasic solution. The organic (upper) phase was cannula transferred to a clean Schlenk and the aqueous residue was washed with ether (2 × 100 ml). The ether extracts were then mixed and dried over sodium sulfate. The dry ether extract was then cannula transferred to a clean Schlenk and dried under vacuum. This gave a pale yellow oil, yield = 27.9 g.

Preparation of 1- (di-tert-butylphosphinomethyl) -2- (diphenylphosphinomethyl) benzene (7) 1- (di-tert-butylphosphino {borane} methyl) -2- (diphenylphosphinomethyl) ) The benzene (6) complex (27.9 g, maximum yield = 55 mmol) was dissolved in MTBE (250 ml). To this was added tetrafluoroboric acid (45.2 ml, 330 mmol). This generated gas and a white precipitate formed. The resulting suspension was then heated to 63 ° C. for 16 hours. The solvent was removed under vacuum to give a pale yellow solution. To this was added KOH (30 g, 455 mmol) in water (75 ml, degassed with nitrogen for 30 min). This formed an off-white precipitate. Diethyl ether (300 ml) was added and the ether soluble material was cannula transferred to a clean Schlenk. The aqueous residue was then washed with diethyl ether (2 × 100 ml). The ether extracts were then mixed and dried over sodium sulfate. The ether extract was then cannula transferred to a clean Schlenk and dried under vacuum. This gave a pale yellow viscous solid. Yield = 8.0 g. The solid was suspended in methanol (50 ml) and heated to reflux, then the resulting solution was cooled to room temperature and left in the freezer overnight. This gave a large amount of off-white solid. The solid was isolated by filtration and dried under vacuum. This gave a free-flowing off-white solid. Yield = 5.6 g, 23%. Purity 95%. ³¹ P ^{1 H. } NMR (CDCl ₃ , 161.9 MHz, δ); 28.4 (s), −13.1 (s) ppm
Preparation of di-iso-propylphosphine borane (10) Di-iso-propylphosphine chloride (40 g, 262.1 mmol) was placed in a Schlenk flask followed by addition of diethyl ether (200 ml). The ether solution was cooled in a cold water bath and LiAlH ₄ (1M in diethyl ether, 150 ml, 150 mmol) was added slowly. This gave a yellow suspension that was stirred overnight at room temperature. The suspension was quenched by the addition of water (50 ml, degassed with nitrogen for 20 minutes). This gave a dibasic solution. The upper layer (organic layer) was cannula transferred to a clean Schlenk and the aqueous residue was washed with an additional 100 ml of ether. The ether extracts were mixed and dried over sodium sulfate. The ether extract was then cannula transferred to a clean Schlenk and the ether removed by distillation. This gave a colorless oil. The colorless oil was then diluted with THF (200 ml) and cooled to 0 ° C., to which was added BH ₃ in THF (1M solution, 300 ml, 300 mmol). The resulting solution was then stirred overnight at room temperature. The solvent was then removed under vacuum to give a colorless oil. Yield = 27.1 g, 79% yield. ³¹ P { ¹ H} NMR (CDCl ₃ , 161.9 MHz, δ); 28.0 (m), ppm
1- (di -tert- butylphosphino {borane} methyl) -2- Preparation of (di - - isopropyl phosphino {borane} methyl) benzene (11) Bu ^t ₂ PH. _{BH 3 (4) (12.12g,} 75.75mmol) was dissolved in THF (100 ml), thereto ^Bu n Li (hexanes 2.5M, 30.5ml, 75.75mmol) was added. The resulting yellow solution was stirred for 1 hour. Cyclic sulfate (3) (15.15 g, 75.75 mmol) was dissolved in THF (100 ml) and cooled to -78 ° C. Then, the lithium phosphide solution was added dropwise to the cyclic sulfate solution. After the addition was complete, the resulting solution was stirred at −78 ° C. for 30 minutes and then warmed to room temperature. The solution was then stirred for 30 minutes at room temperature. The solution was then cooled to -78 ° C.

Di-iso-propylphosphine borane (10) (10 g, 75.75 mmol) was diluted with THF (70 ml) and cooled to 0 ° C. To this was added Bu ⁿ Li (2.5 M in hexane, 30.5 ml, 75.75 mmol). The resulting yellow solution was then warmed to room temperature. The solution was then stirred for 30 minutes at room temperature. This solution was then added dropwise to the cyclic sulfate solution at -78 ° C. After the addition was complete, the solution was stirred at −78 ° C. for 30 minutes, then warmed to room temperature and then stirred overnight. The solution was then removed under vacuum to give a yellow solid / gel. Ether (250 ml) was then added followed by water (100 ml, degassed with nitrogen for 30 minutes). This gave a dibasic solution. The organic (upper) phase was cannula transferred to a clean Schlenk and the aqueous residue was washed with ether (250 ml). The ether extracts were then mixed and dried over sodium sulfate. The dry ether extract was then cannula transferred to a clean Schlenk and dried under vacuum. This gave a pale yellow solid, yield = 30.27 g.

Preparation of 1- (di-tert-butylphosphinomethyl) -2- (di-iso-propylphosphinomethyl) benzene (12) 1- (di-tert-butylphosphino {borane} methyl) -2- ( Di-iso-propylphosphino {borane} methyl) benzene (11) complex (30.27 g, maximum yield = 75.75 mmol) was dissolved in MTBE (300 ml). To this was added tetrafluoroboric acid (63 ml, 454.5 mmol). This generated gas and a white precipitate formed. The resulting suspension was then heated to 57 ° C. for 16 hours. The solvent was removed under vacuum to give a pale yellow solution. To this was added KOH (40 g, 605 mmol) in water (50 ml, degassed with nitrogen for 30 min). This formed an off-white precipitate. Pentane (2 × 250) was added and the pentane soluble material was transferred to a clean Schlenk with a cannula. The pentane extract was then dried over sodium sulfate. The pentane extract was then cannula transferred to a clean Schlenk and dried under vacuum. This gave a pale yellow oil. Yield = 10.0 g. The aqueous residue was then extracted with additional pentane (2 × 250 ml) and the pentane soluble material was cannula transferred to a clean Schlenk. The pentane extract was then dried over sodium sulfate. The pentane extract was then cannula transferred to a clean Schlenk and dried under vacuum. Yield = 4.9 g. Mixing yield = 14.9 g, 54%. Purity 95%. ³¹ P ^{1 H. } NMR (CDCl ₃ , 202.3 MHz, δ); 28.3 (s), 5.1 (s) ppm.

Preparation of 1- (di-tert-butylphosphinomethane) -2- (di-o-tolylphosphinomethane) benzene (6) Phosphine (6) was prepared in a two step process. A cyclic sulfuric acid ^ester, _Bu t 2 PH. Reaction with lithium salt of BH ₃ followed by (o-tolyl) ₂ PH. The reaction was continuously performed with a lithium salt of BH ₃ (4). The intermediate boron-protected phosphine (5) is then deboronated by adding tetrafluoroboric acid, and the bis-phosphonium salt prepared in situ is then free phosphine (by adding potassium hydroxide). Reduced to 7).

Preparation of di-o-tolylphosphine borane (4) Di-o-tolylphosphine chloride (10 g, 40.2 mmol) was placed in a Schlenk flask followed by addition of diethyl ether (200 ml). The ether solution was cooled in a cold water bath and LiAlH ₄ (1M in diethyl ether, 100 ml, 100 mmol) was added slowly. This gave a suspension which was then stirred overnight at room temperature. The suspension was quenched by the addition of water (50 ml, degassed with nitrogen for 20 minutes). This gave a dibasic solution. The upper layer (organic layer) was cannula transferred to a clean Schlenk and the aqueous residue was washed with an additional 100 ml of ether. The ether extracts were mixed and dried over sodium sulfate. The ether extract was then cannula transferred to a clean Schlenk to remove the ether. This gave a white solid. The white solid was then dissolved in THF (200 ml) and cooled to 0 ° C., to which was added BH ₃ in THF (1M solution, 100 ml, 100 mmol). The resulting solution was then stirred overnight at room temperature. The solvent was then removed under vacuum to give a white waxy solid. Yield = 8.5 g, 93%. ³¹ P { ¹ H} NMR (CDCl ₃ , 161.9 MHz, δ); 18.9 (s), ppm
1- (di -tert- butylphosphino {borane} methyl) -2- (di -o- tolylphosphino {borane} methyl) benzene (5) Preparation Bu ^t ₂ PH. BH ₃ (6.11 g, 37.3 mmol) was dissolved in THF (70 ml) and Bu ⁿ Li (2.5 M in hexane, 15.0 ml, 37.3 mmol) was added thereto. The resulting yellow solution was stirred for 1 hour. Cyclic sulfate (3) (7.46 g, 37.3 mmol) was dissolved in THF (100 ml) and cooled to -78 ° C. The lithium phosphide solution was then added dropwise to the cyclic sulfate solution. After the addition was complete, the resulting solution was stirred at −78 ° C. for 30 minutes and then warmed to room temperature. The solution was then stirred at room temperature for 3 hours. The solution was then cooled to -78 ° C.

Bis (o-tolyl) phosphine borane (4) (8.50 g, 37.3 mmol) was dissolved in THF (70 ml). To this was added Bu ⁿ Li (2.5 M in hexane, 15.0 ml, 37.3 mmol). The resulting orange / red solution was then added dropwise to the cyclic sulfate solution at −78 ° C. After the addition was complete, the solution was stirred at −78 ° C. for 30 minutes, then warmed to room temperature and then stirred overnight. The solution was then removed under vacuum to give a yellow solid / gel. Ether (250 ml) was then added, followed by water (100 ml, degassed with nitrogen for 30 minutes). This gave a dibasic solution. The organic (upper) phase was cannula transferred to a clean Schlenk and the aqueous residue was washed with ether (2 × 100 ml). The ether extracts were then mixed and dried over sodium sulfate. The dried ether extract was then cannula transferred to a clean Schlenk and dried under vacuum. This gave a pale yellow oil, yield = 13.3 g.

Preparation of 1- (di-tert-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) benzene (6) 1- (di-tert-butylphosphino {borane} methyl) -2- ( Di-o-tolylphosphino {borane} methyl) benzene (5) complex (13.3 g, maximum yield = 37.3 mmol) was dissolved in MTBE (250 ml). To this was added tetrafluoroboric acid (31.0 ml, 273.7 mmol). This generated gas and a white precipitate formed. The resulting suspension was then heated to 63 ° C. for 16 hours. The solvent was removed under vacuum to give a pale yellow solution. To this was added KOH (30 g, 300 mmol) in water (75 ml, degassed with nitrogen for 30 min). This formed an off-white precipitate. Pentane (300 ml) was added and the ether soluble material was cannula transferred to a clean Schlenk. The aqueous residue was then washed with pentane (200 ml). The pentane extract was then mixed and dried over sodium sulfate. The ether extract was then cannula transferred to a clean Schlenk and dried under vacuum. This gave a pale orange solid. Yield = 9.7g. The solid was suspended in methanol (40 ml) and heated to reflux, then the resulting white suspension was cooled to room temperature and the methanol soluble material was removed by cannula. The insoluble white material was then dried under vacuum and isolated in a glove box. Yield = 3.4 g, 24%. Purity 95%. ³¹ P ^{1 H. } NMR (CDCl ₃ , 161.9 MHz, δ); 29.8 (s), −35.0 (s) ppm
Preparation of 1,2-bis (1,3,5,7-tetramethyl-2,4,8-trioxa-6-phosphaadamantanemethyl) benzene (14) 1,3,5,7-tetramethyl-2 Phosphine (14) was prepared by adding lithium salt of, 4,8-trioxa-6-phosphaadamantanborane (8) and dichloro-o-xylene. The intermediate boron-protected phosphine was then deprotected by adding diethylamine to give the target molecule.

Preparation of 1,3,5,7-tetramethyl-2,4,8-trioxa-6-phosphaadamantanborane (8) Phosphine 1,3,5,7-tetramethyl-2,4,8-trioxa- 6-phosphaadamantane (7.34 g, 34 mmol) (7) was placed in a 500 ml Schlenk flask. To this was added BH ₃ (1M in THF, 100 ml, 100 mmol). The resulting solution was then allowed to stand overnight. Boraneated phosphine was kept in solution until needed.

Preparation of 1,2-bis (1,3,5,7-tetramethyl-2,4,8-trioxa-6-phosphaadamantanemethyl) benzene (14) 1,3,5,7-tetramethyl-2 , 4,8-Trioxa-6-phosphaadamantanborane solution (8) (70 mmol) was dried under vacuum and then redissolved in THF (100 ml). The THF solution was then cooled to −78 ° C., Bu ⁿ Li (2.5 M in hexane, 28.0 ml, 70 mmol) was added and the solution was then added to the 1,2-bis (chloromethyl) benzene solution (6 0.08 g, 35 mmol) was added immediately at −78 ° C. The resulting solution was then stirred at −78 ° C. for 30 minutes before warming to room temperature and stirring overnight at room temperature. After 90 minutes, a white suspension was observed. Diethylamine (40 ml, degassed with nitrogen for 20 minutes) was added to the suspension and the suspension was heated to reflux for 2 hours. The resulting suspension was then cooled to room temperature and then dried under vacuum. The residue was suspended in toluene (300 ml) and then water (100 ml, degassed with nitrogen for 20 minutes) was then added. The upper (organic) phase was cannula transferred to a clean Schlenk flask and the solvent removed in vacuo. This gave a white paste which was then suspended in methanol (40 ml). The suspension was then heated to reflux and then cooled to room temperature. The methanol soluble material was removed by cannula and the white solid was dried under vacuum. The white solid was then isolated in a glove box. Yield = 10.5g. Purity 95%. ³¹ P ^{1 H. } NMR (CDCl ₃ , 161.9 MHz, δ); 28.4 (s), −13.1 (s) ppm
Preparation of cyclic sulfate (1) 1,2-benzenedimethanol (21.2 g, 153 mmol) was partially dissolved in dichloromethane (250 ml). To this was slowly added thionyl chloride (13.8 ml, 189 mmol). This generated a large amount of gas. The resulting solution was then heated to reflux (50 ° C.) for 90 minutes. The resulting solution was then cooled to room temperature and stirred overnight. The solvent was then removed under vacuum to give a light brown oil. The residue was then diluted with dichloromethane (100 ml), acetonitrile (100 ml) and water (150 ml). To the resulting dibasic solution was added sodium periodate (65.3 g, 305.3 mmol) and ruthenium trichloride hydrate (300 mg). The resulting suspension was then stirred at room temperature for 1 hour during which a large amount of white precipitate formed. The final suspension was diluted with water (100 ml) and ether (100 ml) was added. The organic layer was collected by separation and the aqueous residue was washed with ether (2 × 100 ml). The mixed organic extract was then washed with water (2 × 200 ml) and dried over sodium sulfate. The organic extract was then filtered through celite-containing filter paper. This gave a colorless solution. The solvent was then removed under vacuum to give an off-white solid. The solid was stored in a -20 ° C freezer. Yield = 24.6 g, 80%. 99% purity by ¹ H NMR.

Preparation of di-tert-butylphosphine borane (2) Di-tert-butylphosphine chloride (34 g, 188.41 mmol) was placed in a Schlenk flask and then diethyl ether (200 ml) was added. The ether solution was cooled in a cold water bath and LiAlH ₄ (1M in diethyl ether, 100 ml, 100 mmol) was added slowly. This gave a yellow suspension that was stirred overnight at room temperature. The suspension was quenched by the addition of water (50 ml, degassed with nitrogen for 20 minutes). This gave a dibasic solution. The upper layer (organic layer) was cannula transferred to a clean Schlenk and the aqueous residue was washed with an additional 100 ml of ether. The ether extracts were mixed and dried over sodium sulfate. The ether extract was then cannula transferred to a clean Schlenk and the ether removed by distillation. This gave a colorless oil. The colorless oil was then diluted with THF (200 ml) and cooled to 0 ° C., to which was added BH ₃ in THF (1M solution, 250 ml, 250 mmol). The resulting solution was then stirred overnight at room temperature. The solvent was then removed under vacuum to give a white crystalline solid which was then isolated in a glove box. Yield = 22.1 g, 73% yield. ³¹ P { ¹ H} NMR (80 MHz, CDCl ₃ , δ): δ 49.23 ppm (multiple line).

Preparation of bis (o-ethylphenyl) phosphine oxide (3a) A 1 L Schlenk flask was charged with small pieces (4 cm) of magnesium ribbon (7.23 g, 297.5 mmol). To this was added some crystals of iodine and THF (400 ml). The solution was then placed in a warm water bath for 20 minutes until the orange color of the solution faded to pale yellow. The warm water bath was then removed and oxalate (50 g, 270.4 mmol) was added dropwise over 90 minutes. This gave a brown solution and a small amount of unreacted magnesium. The solution was then stirred at room temperature for 30 minutes before diethyl phosphite (11.22 ml, 87.2 mmol) was added dropwise. The resulting solution was then stirred overnight. The reaction was quenched with hydrochloric acid (50 ml) and it was added slowly to the reaction solution. This was then followed by the addition of water (200 ml) and toluene (300 ml). This gave a two-phase solution. The upper organic phase was collected by separation and washed with water (200 ml), saturated potassium carbonate solution (200 ml) and water (200 ml). The organic phase was then dried over magnesium sulfate and then filtered. The filtrate was then dried under vacuum to give a pale yellow solid (3a). Yield = 17.21 g, 76%.

Preparation of bis (o-ethylphenyl) phosphine (3b) A 1 L Schlenk flask was charged with phosphine oxide (3a) (17.21 g, 66.7 mmol). To this was added acetonitrile (400 ml) and triethylamine (27.9 ml, 200.1 mmol). Then trichlorosilane (20.2 ml, 200.1 mmol) was added slowly. By adding trichlorosilane, some white precipitate was formed. The resulting mixture was then refluxed overnight. The resulting suspension was then cooled to 0 ° with an ice bath and to it was slowly added a solution of potassium hydroxide (40 g) in water (200 ml) degassed with nitrogen gas. This gave a two-phase mixture. Then additional acetonitrile (100 ml) was added. The upper organic phase was then cannulated into a clean Schlenk flask and the solvent removed under vacuum. This gave an off-white solid (3b). Yield = 13.60 g, 84%.

1- (di -tert- butylphosphino {borane} methyl) -2- (di -o- ethyl phosphino) benzene (3c) Preparation Bu ^t ₂ PH. BH ₃ (2) (9.27 g, 56.2 mmol) was dissolved in THF (100 ml) and Bu ⁿ Li (2.5 M in hexane, 22.5 ml, 56.2 mmol) was added thereto. The resulting yellow solution was stirred for 1 hour. Cyclic sulfate (1) (11.24 g, 56.2 mmol) was dissolved in THF (100 ml) and cooled to -78 ° C. Then, the lithium phosphide solution was added dropwise to the cyclic sulfate solution. After the addition was complete, the resulting solution was stirred at −78 ° C. for 30 minutes and then warmed to room temperature. The solution was then stirred at room temperature for 30 minutes. The solution was then cooled to -78 ° C.

Bis (o-ethylphenyl) phosphine (3b) (13.60 g, 56.2 mmol) was dissolved in THF (100 ml). To this was added Bu ⁿ Li (2.5 M in hexane, 22.5 ml, 56.2 mmol) at −78 ° C., which formed an orange / red solution. The resulting solution was then stirred for 30 minutes before being removed from the cold bath and then slowly added to the cyclic sulfate solution at -78 ° C. After the addition was complete, the solution was stirred at −78 ° C. for 30 minutes, then warmed to room temperature and then stirred overnight. The solvent was then removed under vacuum to give a yellow solid / gel. Ether (350 ml) was then added, followed by water (100 ml, degassed with nitrogen for 30 minutes). This gave a dibasic solution. The organic (upper) phase was cannula transferred to a clean Schlenk and the aqueous residue was washed with ether (2 × 100 ml). The ether extracts were then mixed and dried over sodium sulfate. The dried ether extract was then cannula transferred to a clean Schlenk and dried under vacuum. This gave a white solid, yield = 18.2 g.

Preparation of 1- (di-tert-butylphosphinomethyl) -2- (di-o-ethylphosphinomethyl) benzene (3d) 1- (di-tert-butylphosphinomethyl) -2- (di-o -Tolylphosphinomethyl) benzene complex (3d) (18.2 g, maximum yield = 56.2 mmol) was dissolved in MTBE (400 ml). To this was added tetrafluoroboric acid (46.3 ml, 337.2 mmol). This generated gas and a white precipitate formed. The resulting suspension was then heated to 63 ° C. overnight. The solvent was then removed under vacuum to give a pale yellow solution. To this was added KOH (40 g, 606 mmol) in water (200 ml, degassed with nitrogen for 30 min). This formed an off-white precipitate. Pentane (400 ml) was added and the pentane soluble material was cannula transferred to a clean Schlenk. The aqueous residue was then washed with pentane (100 ml). The pentane extracts were then mixed and dried under vacuum. This gave a pale yellow solid. The solid was then suspended in methanol (40 ml) and heated to reflux, then the resulting white suspension was cooled to room temperature and the methanol soluble material was removed by cannula. The insoluble white material was then dried under vacuum. Yield = 9.2 g, the sample was not pure enough to be used in the catalysis, so additional purification steps were added.

Purification of 1- (di-tert-butylphosphinomethyl) -2- (di-o-ethylphosphinomethyl) benzene (3d) Crude phosphine (9.2 g, assumed to be 18.78 mmol when 100% pure) ) Was dissolved in diethyl ether (400 ml). To this was added methanesulfonic acid (1.22 ml, 18.78 mmol), which immediately formed a white suspension, then the ether soluble material was cannulated into a clean Schlenk flask and the residue was dried under vacuum I let you. To the ether soluble material again an additional equivalent of methanesulfonic acid (1.22 ml, 18.78 mmol) was added, which immediately formed a white suspension. The ether soluble material was then cannula transferred to a clean Schlenk flask and the residue was dried under vacuum. The initial ether insoluble residue was reacted with a solution of potassium hydroxide (2.48 g, 37.56 mmol) in water (50 ml, degassed with nitrogen gas for 30 minutes). This formed a white suspension. Then pentane (400 ml) was added and the suspension was stirred rapidly for 20 minutes. The upper organic phase was then cannula transferred to a clean Schlenk flask and the solvent removed under vacuum. This gave a white solid, yield = 3.71 g, 13%, which was> 95% pure by ³¹ P { ¹ H} and ¹ H NMR. This was then removed from the flask and stored in a glove box.

  The second ether insoluble fraction was reacted with a solution of potassium hydroxide (2.48 g, 37.56 mmol) in water (50 ml, degassed with nitrogen gas for 30 minutes). This formed a white suspension. Then pentane (400 ml) was added and the suspension was stirred rapidly for 20 minutes. The upper organic phase was then cannula transferred to a clean Schlenk flask and the solvent removed under vacuum. This gave a white solid, yield = 1.90 g, which was about 80% pure by NMR.

Examples of Carbonylation Overview Carbonylation was performed as follows and the results for the ligands of Examples 1-6 and Comparative Examples 1 and 2 are shown in Tables 1-7.

Reuse Examples Experiments Using standard Schlenk tube techniques, 22 mg Pd (OAc) ₂ (0.1 mmol) and 0.5 mmol ligand (5 molar equivalents) were dissolved in 300 ml methanol solvent. A reaction solution was prepared. After complexing the palladium and ligand, 2.92 ml (45 mmol) of methanesulfonic acid (450 molar equivalents) was added to complete the preparation of the catalyst solution.

When the catalyst solution was placed in an autoclave previously evacuated and heated to 100 ° C., the pressure generated by the solvent at that time was 23 × 10 ⁴ Pa (2.3 bar). The autoclave was then pressurized to 123 × 10 ⁴ Pa (12.3 bar) by adding CO: ethene (1: 1 gas) charged from a 10 liter reservoir at high pressure. By injecting a constant gas from a 10 liter reservoir using a normal valve, the autoclave pressure is reliably maintained at 123 × 10 ⁴ Pa (12.3 bar) throughout the reaction. Reservoir pressure as well as reactor temperature were recorded during the 3 hour reaction period. The moles of product produced at any point in the reaction were calculated from the decrease in reservoir pressure by assuming ideal gas behavior and 100% selectivity for methyl propionate, and using the specific ligand The TON of the reaction can be obtained.

  After the reaction period, the autoclave was cooled and evacuated. The reaction solution was collected from the bottom of the vessel and immediately placed under an inert atmosphere. In the example with recycling, the solution was then reduced to about 20 ml under pressure. This concentrated solution was left overnight under an inert atmosphere and then 300 ml of methanol was added and used to form the base of the next reaction solution. The recycled material was then placed in an autoclave and reacted under the same set of conditions as before. The catalyst was reused in this manner until a significant decrease in reaction TON was observed.

Selectivity for the product was determined using GC calibrated with the appropriate standard.
Example 1
Examples 1 and 2 show surprisingly high catalyst turnover in ethylene carbonylation using asymmetric ligands that do not have a tertiary carbon atom on one of the phosphorus atoms, but show polymerization. Not. Comparative Example 1 shows the results for a ligand having a tertiary carbon atom on both phosphorus atoms (1,2-bis- (2-phospha-adamantyl) o-xylene). It can be seen that systems using asymmetric aromatic bridging ligands having non-tertiary carbon atoms are superior to ligands substituted exclusively with tertiary carbon atoms.

Example 3
Examples 3 and 4 show that the ligand is remarkably stable and can continue to give good results after several reuses.

Examples 5 and 6
The following examples show that decomposition or polymerization does not occur even at high temperatures, and still high catalyst rotation speeds are obtained.

The reader's attention is directed to all articles and documents published in this specification, which are filed simultaneously with or prior to this specification in connection with the present application. The contents are incorporated herein by reference.

  All of the features disclosed in this specification (including any of the appended claims, abstracts and drawings) and / or any of the methods or steps of any method so disclosed are all such features and / or Alternatively, combinations can be made in any combination except combinations where at least some of the steps are mutually exclusive.

  Each feature disclosed in this specification (including any of the appended claims, abstract, and drawings) is intended to be by alternative features serving the same, equivalent, or similar purpose unless otherwise indicated. Can be replaced. Thus, unless expressly stated otherwise, each feature disclosed is one example only of a generic series of equivalent or similar features.

  The present invention is not limited to the details of the embodiments described above. The present invention relates to any novel feature, any feature combination, any method, or method step disclosed in the specification, including any of the appended claims, abstract and drawings. It extends to any novel one or any combination.

Claims (26)

A novel bidentate ligand of the general formula (I),


Where
A and B independently represents a methylene linking group, or one other of Q ¹ and Q one is a direct bond vital Q ¹ to R ² and Q ² is A and B so as not to bind directly to the R Is omitted, the other of A and B represents a methylene linking group,
R represents a hydrocarbyl aromatic structure having at least one aromatic ring, and when the methylene linking group is present, the at least one aromatic ring can be used via the methylene linking group. Q ¹ and Q ² are bonded to adjacent atoms, respectively,
The groups X ³ and X ⁴ independently represent a monovalent group of up to 30 atoms having at least one tertiary carbon atom, or X ³ and X ^{4 taken} together are at least two three form a divalent radical of up to 40 atoms having grade carbon atoms, the monovalent or divalent each group are, respectively it via the at least one or two tertiary carbon atoms atom Q ¹ And
The groups X ¹ and X ² independently represent a monovalent group of up to 30 atoms having at least one primary or aromatic carbon atom, in which case the carbon bonded to the Q ² atom is Q is an aromatic carbon that forms part of an aromatic ring that is substituted at the ortho or meta position of the ring with respect to the A ² atom, or X ¹ and X ² together are at least two primary or form a divalent radical of up to 40 atoms having an aromatic carbon atom, in the latter case, the carbon bonded to Q ² atoms, substituted in the ortho or meta position of the ring relative to the Q ² atoms an aromatic carbon which forms part of an aromatic ring that is, the monovalent or divalent each group of said at least through one or two primary or aromatic carbon atoms, their respective nuclear It is bound to ^{Q 2,} Q ¹ and ^{Q 2,} Germany To, phosphorus, it represents arsenic or antimony, bidentate ligands. A method for carbonylation of an ethylenically unsaturated compound, comprising:
In the presence of a source of hydroxyl groups, optionally an anion source and a catalyst system, acetylene, methylacetylene, propylacetylene, 1,3-butadiene, ethylene, propylene, butylene, isobutylene, pentene, pentenenitrile, alkylpenteno. Reacting an ethylenically unsaturated compound selected from art, pentenoic acid, heptene, octene, dodecene and mixtures thereof with carbon monoxide,
The catalyst system is
(A) a Group 8, 9 or 10 metal or a compound thereof;
(B) a bidentate ligand of general formula (I),


Where
A and B independently represents a methylene linking group, or one other of Q ¹ and Q one is a direct bond vital Q ¹ to R ² and Q ² is A and B so as not to bind directly to the R Is omitted, the other of A and B represents a methylene linking group,
R represents a hydrocarbyl aromatic structure having at least one aromatic ring, and when the methylene linking group is present, the at least one aromatic ring can be used via the methylene linking group. Q ¹ and Q ² are bonded to adjacent atoms, respectively,
The groups X ³ and X ⁴ independently represent a monovalent group of up to 30 atoms having at least one tertiary carbon atom, or X ³ and X ^{4 taken} together are at least two three form a divalent radical of up to 40 atoms having grade carbon atoms, the monovalent or divalent each group through one or two tertiary carbon atoms said at least each, respectively it Hara Is connected to child Q ¹ and
The groups X ¹ and X ² independently represent a monovalent group of up to 30 atoms having at least one primary, secondary or aromatic carbon atom, or X ¹ and X ^{2 taken} together Form a divalent group of up to 40 atoms having at least two primary, secondary or aromatic carbon atoms, each monovalent or divalent group being said at least one or two primary, through the secondary or aromatic carbon atoms, their respective are bound to the atom Q ^2,
A method for the carbonylation of an ethylenically unsaturated compound, characterized in that Q ¹ and Q ² are independently obtained by combining the bidentate ligands representing phosphorus, arsenic or antimony. Said groups X ¹ and X ² are C ₁ -C ₂₀ alkyl, C ₂ -C ₂₀ alkenyl, C ₂ -C ₂₀ alkynyl or C ₅ substituted in the ortho or meta position of the ring relative to the Q ² atom -C ₂₀ is selected from aryl group, a bidentate ligand of claim 1. The group X ¹ represents an Ar group substituted at the ortho or meta position of the ring relative to the Q ² atom, and / or the group X ² is substituted at the ortho or meta position of the ring relative to the Q ² atom. The bidentate ligand according to claim 1 or 3, which represents a substituted Ar group. 5. The bidentate ligand according to claim 1, wherein at least one of the groups X ¹ or X ² comprises one or more substituents. Wherein the substituents contained in X ¹ or X ² is on a carbon directly adjacent to the carbon which is directly bonded to the Q ² atom, the bidentate ligand of claim 5. The X ¹ and / or X ² group has an α carbon atom, and the α carbon atom of the X ¹ and / or X ² group is an aliphatic secondary or tertiary carbon atom. Item 7. The bidentate ligand according to any one of Items 3 to 6. The carbon bonded to the Q ² atom is an aromatic carbon, and the aromatic carbon is substituted on an atom adjacent to the ring atom bonded to the Q ² atom. The bidentate ligand according to any one of claims 1 and 3 to 7, which forms a part. Said _{substituents,} C 1 -C ₇ alkyl group, _O-C 1 ~C ₇ alkyl group, -CN, -F, -Si ^{_{(alkyl) 3, -COOR 63, -C (}} O) -, or -CF _The bidentate ligand according to claim 5 or 6, wherein R ⁶³ is alkyl, aryl or Het. The bidentate according to any one of claims 1 or 3 to 7, wherein the X ¹ and X ² groups are phenyl groups substituted with C ₁ -C ₇ alkyl or O-C ₁ -C ₇ alkyl. Ligand. The carbon attached to Q ² atom is an aromatic carbon which forms part of an aromatic ring, bidentate ligand of claim 1. The X ¹ or X ² group is methyl, ethyl, propyl, 2-methyl-phen-1-yl, 2-methoxy-phen-1-yl, 2-fluoro-phen-1-yl, 2-trifluoromethyl; -Phen-1-yl, 2-trimethylsilyl-phen-1-yl , 3 -methyl-phen-1-yl, butyl, pentyl, neopentyl, 2-ethyl-phen-1-yl, 2-propyl-phen-1 11. A bidentate ligand according to any one of claims 1 or 3 to 10, selected from the group consisting of -yl and 2-prop-2'-yl-phen-1-yl. 1- (di-tert-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) benzene, 1- (di-tert-pentylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) benzene Methyl) benzene, 1- (di-tert-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) naphthalene, 1- (diadamantylphosphinomethyl) -2- (di-o-tolylphos) Finomethyl) benzene, 1- (di-3,5-dimethyladamantylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) benzene, 1- (di-5-tert-butyladamantylphosphinomethyl) 2- (di-o-tolylphosphinomethyl) benzene, 1- (1-adamantyl tert-butyl-phosphinomethyl) -2- (di-o-to Ruphosphinomethyl) benzene, 1- (2,2,6,6-tetramethyl-phospha-cyclohexane-4-one) -2- (di-o-tolylphosphino) -o-xylene, 1- (2- ( Phospha-adamantyl))-2- (di-o-tolylphosphino) -o-xylene, 1- (dicongresylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) benzene, 1- (di- tert-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) ferrocene, 1- (di-tert-pentylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) ferrocene, -(Diadamantylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) ferrocene, 1- (di-3,5-dimethyladamantylphosphinomethy) ) -2- (di-o-tolylphosphinomethyl) ferrocene, 1- (di-5-tert-butyladamantylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) ferrocene, 1- (1 -Adamantyl tert-butyl-phosphinomethyl) -2- (di-o-tolylphosphinomethyl) ferrocene, 1- (2,2,6,6-tetramethyl-phospha-cyclohexane-4-one) -2- (Di-o-tolylphosphino) -1,2-dimethylferrocene, 1- (2- (phospha-adamantyl))-2- (di-o-tolylphosphino) -1,2-dimethylferrocene, 1- (dicongresyl) Phosphinomethyl) -2- (di-o-tolylphosphinomethyl) ferrocene, 1- (di-o-tolylphosphinomethyl) -2,3-bis- (dite rtbutylphosphinomethyl) ferrocene;
1- (di-t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4,5-diphenylbenzene; 1- (di-t-butylphosphinomethyl) -2- (di -O-tolylphosphinomethyl) -4-phenylbenzene; 1- (di-t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4,5-bis- (trimethylsilyl) benzene 1- (di-t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4- (trimethylsilyl) benzene; 1- (di-t-butylphosphinomethyl) -2- ( Di-o-tolylphosphinomethyl) -4,5-di- (2'-phenylprop-2'-yl) benzene; 1- (di-t-butylphosphinomethyl) -2- (di-o- Tolylphosphinomethyl) -4 (2′-phenylprop-2′-yl) benzene; 1- (di-t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4,5-di-t-butylbenzene 1- (di-t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4-t-butylbenzene;
1- (2-phosphinomethyl-adamantyl) -2- (di-o-tolylphosphinomethyl) -4,5-diphenylbenzene; 1- (2-phosphinomethyl-adamantyl) -2- (di-o -Tolylphosphinomethyl) -4-phenylbenzene; 1- (2-phosphinomethyl-adamantyl) -2- (di-o-tolylphosphinomethyl) -4,5-bis- (trimethylsilyl) benzene; (2-phosphinomethyl-adamantyl) -2- (di-o-tolylphosphinomethyl) -4- (trimethylsilyl) benzene; 1- (2-phosphinomethyl-adamantyl) -2- (di-o-tolyl) Phosphinomethyl) -4,5-di- (2′-phenylprop-2′-yl) benzene; 1- (2-phosphinomethyl-adamantyl) -2- (di-o-tri Phosphinomethyl) -4- (2′-phenylprop-2′-yl) benzene; 1- (2-phosphinomethyl-adamantyl) -2- (di-o-tolylphosphinomethyl) -4,5- (Di-t-butyl) benzene; 1- (2-phosphinomethyl-adamantyl) -2- (di-o-tolylphosphinomethyl) -4-t-butylbenzene;
1- (di-adamantylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4,5 diphenylbenzene; 1- (di-adamantylphosphinomethyl) -2- (di-o-tolylphos) 1- (di-adamantylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4,5bis- (trimethylsilyl) benzene; 1- (di-adamantylphos) Finomethyl) -2- (di-o-tolylphosphinomethyl) -4- (trimethylsilyl) benzene; 1- (di-adamantylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4, 5-di- (2′-phenylprop-2′-yl) benzene; 1- (di-adamantylphosphinomethyl) -2- (di-o-tolylphosphinomethy ) -4- (2′-phenylprop-2′-yl) benzene; 1- (di-adamantylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4,5- (di-t -Butyl) benzene; 1- (di-adamantylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4-t-butylbenzene;
1- (P- (2,2,6,6-tetramethyl-phospha-cyclohexane-4-one))-2- (di-o-tolylphosphinomethyl) -4,5 diphenylmethylbenzene; P- (2,2,6,6-tetramethyl-phospha-cyclohexane-4-one))-2- (di-o-tolylphosphinomethyl) -4-phenylmethylbenzene; 1- (P- (2 , 2,6,6-tetramethyl-phospha-cyclohexane-4-one))-2- (di-o-tolylphosphinomethyl) -4,5bis- (trimethylsilyl) methylbenzene; 1- (P- ( 2,2,6,6-tetramethyl-phospha-cyclohexane-4-one))-2- (di-o-tolylphosphinomethyl) -4- (trimethylsilyl) methylbenzene; 1- (P- (2, 2,6,6-te Lamethyl-phospha-cyclohexane-4-one))-2- (di-o-tolylphosphinomethyl) -4,5-di- (2′-phenylprop-2′-yl) methylbenzene; 1- (P -(2,2,6,6-tetramethyl-phospha-cyclohexane-4-one))-2- (di-o-tolylphosphinomethyl) -4- (2'-phenylprop-2'-yl) 1- (P- (2,2,6,6-tetramethyl-phospha-cyclohexane-4-one))-2- (di-o-tolylphosphinomethyl) -4,5- (di- t-butyl) methylbenzene; 1- (P- (2,2,6,6-tetramethyl-phospha-cyclohexane-4-one))-2- (di-o-tolylphosphinomethyl) -4-t -Butylmethylbenzene;
1- (P, P adamantyl, t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4,5-diphenylbenzene; 1- (P, P adamantyl, t-butylphosphinomethyl) ) -2- (Di-o-tolylphosphinomethyl) -4-phenylbenzene; 1- (P, P adamantyl, t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4 , 5-bis- (trimethylsilyl) benzene; 1- (P, P adamantyl, t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4- (trimethylsilyl) benzene; , P adamantyl, t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4,5-di- (2′-phenylprop-2′-yl) benzene; 1 (P, P adamantyl, t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4- (2′-phenylprop-2′-yl) benzene; 1- (P, P adamantyl , T-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4,5- (di-t-butyl) benzene; 1- (P, P adamantyl, t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4-t-butylbenzene;
1- (di-t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4,5-diphenylferrocene; 1- (di-t-butylphosphinomethyl) -2- (di -O-tolylphosphinomethyl) -4- (or 1 ') phenylferrocene; 1- (di-t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4,5-bis 1- (di-t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4- (or 1 ′) (trimethylsilyl) ferrocene; 1- (di-t Butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4,5-di- (2′-phenylprop-2′-yl) ferrocene; 1- (di-t-butylphosphinomethyl) ) -2- (Di- o-tolylphosphinomethyl) -4- (or 1 ') (2'-phenylprop-2'-yl) ferrocene; 1- (di-t-butylphosphinomethyl) -2- (di-o-tolyl) Phosphinomethyl) -4,5-di-t-butylferrocene; 1- (di-t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4- (or 1 ') t -Butylferrocene;
1- (2-phosphinomethyl-adamantyl) -2- (di-o-tolylphosphinomethyl) -4,5-diphenylferrocene; 1- (2-phosphinomethyl-adamantyl) -2- (di-o -Tolylphosphinomethyl) 4- (or 1 ') phenylferrocene; 1- (2-phosphinomethyl-adamantyl) -2- (di-o-tolylphosphinomethyl) -4,5-bis- (trimethylsilyl) 1- (2-phosphinomethyl-adamantyl) -2- (di-o-tolylphosphinomethyl) 4- (or 1 ') (trimethylsilyl) ferrocene; 1- (2-phosphinomethyl-adamantyl)- 2- (Di-o-tolylphosphinomethyl) -4,5-di- (2′-phenylprop-2′-yl) ferrocene; 1- (2-phosphinomethyl-ada Mantyl) -2- (di-o-tolylphosphinomethyl) -4- (or 1 ') (2'-phenylprop-2'-yl) ferrocene; 1- (2-phosphinomethyl-adamantyl) -2 -(Di-o-tolylphosphinomethyl) -4,5- (di-t-butyl) ferrocene; 1- (2-phosphinomethyl-adamantyl) -2- (di-o-tolylphosphinomethyl)- 4- (or 1 ') t-butylferrocene;
1- (di-adamantylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4,5 diphenylferrocene; 1- (di-adamantylphosphinomethyl) -2- (di-o-tolylphos) 1- (di-adamantylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4,5bis- (trimethylsilyl) ferrocene; (Di-adamantylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4- (or 1 ') (trimethylsilyl) ferrocene; 1- (di-adamantylphosphinomethyl) -2- (di- o-tolylphosphinomethyl) -4,5-di- (2′-phenylprop-2′-yl) ferrocene; 1- (di-adamantylphosphinomethyl)- 2- (di-o-tolylphosphinomethyl) -4- (or 1 ') (2'-phenylprop-2'-yl) ferrocene; 1- (di-adamantylphosphinomethyl) -2- (di- o-tolylphosphinomethyl) -4,5- (di-t-butyl) ferrocene; 1- (di-adamantylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4- (or 1 ') T-Butylferrocene;
1- (P, P adamantyl, t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4,5-diphenylferrocene; 1- (P, P adamantyl, t-butylphosphinomethyl) ) -2- (di-o-tolylphosphinomethyl) -4- (or 1 ′) phenylferrocene; 1- (P, P adamantyl, t-butylphosphinomethyl) -2- (di-o-tolylphos) Finomethyl) -4,5-bis- (trimethylsilyl) ferrocene; 1- (P, P adamantyl, t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4- (or 1 ' ) (Trimethylsilyl) ferrocene; 1- (P, P adamantyl, t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4,5-di- (2′-pheni) Prop-2′-yl) ferrocene; 1- (P, P adamantyl, t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4- (or 1 ′) (2′-phenyl) Prop-2′-yl) ferrocene; 1- (P, P adamantyl, t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4,5- (di-t-butyl) ferrocene 1- (P, P adamantyl, t-butylphosphinomethyl) -2- (di-o-tolylphosphinomethyl) -4- (or 1 ′) t-butylferrocene;
1- (P- (2,2,6,6-tetramethyl-phospha-cyclohexane-4-one))-2- (di-o-tolylphosphinomethyl) -4,5 diphenyl-methylferrocene; (P- (2,2,6,6-tetramethyl-phospha-cyclohexane-4-one))-2- (di-o-tolylphosphinomethyl) -4- (or 1 ') phenyl-methylferrocene; 1- (P- (2,2,6,6-tetramethyl-phospha-cyclohexane-4-one))-2- (di-o-tolylphosphinomethyl) -4,5bis- (trimethylsilyl) -methyl 1- (P- (2,2,6,6-tetramethyl-phospha-cyclohexane-4-one))-2- (di-o-tolylphosphinomethyl) -4- (or 1 ') ( Trimethylsilyl) -methyl 1- (P- (2,2,6,6-tetramethyl-phospha-cyclohexane-4-one))-2- (di-o-tolylphosphinomethyl) -4,5-di- (2 '-Phenylprop-2'-yl) -methylferrocene; 1- (P- (2,2,6,6-tetramethyl-phospha-cyclohexane-4-one))-2- (di-o-tolylphos Finomethyl) -4- (or 1 ') (2'-phenylprop-2'-yl) -methylferrocene; 1- (P- (2,2,6,6-tetramethyl-phospha-cyclohexane-4-) ON))-2- (di-o-tolylphosphinomethyl) -4,5- (di-t-butyl) -methylferrocene; 1- (P- (2,2,6,6-tetramethyl-phospha) -Cyclohexane-4-one))-2- (di-o-tolylphosph Nomechiru) -4- (or 1 ') t-butyl - methyl ferrocene;
The bidentate ligand according to claim 1, selected from the group consisting of: or the group consisting of o-ethylphenyl and o-methoxyphenyl analogues of the aforementioned o-tolyl ligand. The group X ¹ represents CH (R ² ) (R ³ ), X ² represents CH (R ⁴ ) (R ⁵ ), X ³ represents CR ⁷ (R ⁸ ) (R ⁹ ), and X ⁴ There ^CR 10 ^(R 11) represents ^{(R 12), R 2} and ^{R 4} represent ^hydrogen, R 3, ^{R 5} and ^R 7 ^{to R 12} represents alkyl, aryl or H et, claim 1,3 The bidentate ligand according to any one of 5 to 7, 9. X ³ represents CR ⁷ (R ⁸ ) (R ⁹ ), X ⁴ represents CR ¹⁰ (R ¹¹ ) (R ¹² ), and the organic groups R ^{7 to} R ⁹ and / or R ^{10 to} R ¹² or R ⁷ to R ¹² is, when bound to their respective tertiary carbon atom, form composite groups which are at least as sterically hindered and t- butyl, as claimed in any one of claims 1 or 3 to 14 Bidentate ligand. A novel complex comprising a bidentate ligand according to any one of claims 1 or 3 to 15, which is coordinated to a Group 8, 9 or 10 metal or a compound thereof. The method for carbonylation of an ethylenically unsaturated compound according to claim 2, wherein the ethylenically unsaturated compound is ethylene. The bidentate ligand according to any one of claims 1 or 3 to 15, wherein A and B are methylene. The catalyst system also includes an acid present in a molar excess of greater than 2: 1 compared to the ligand, wherein the ligand is at least 2: 1 compared to the metal or the metal of the metal compound. The method for carbonylation of an ethylenically unsaturated compound according to claim 2 or 17, which is present in a molar excess. a) Group 8, 9 or 10 metal or compound thereof,
b) obtainable by combining a bidentate phosphine of formula I, an arsine or stibine ligand according to any one of claims 1 or 3 to 15 or 18 and optionally an acid, ethylene Catalyst system capable of catalyzing the carbonylation of an unsaturated compound. The ligand is present in at least a 2: 1 molar excess compared to the metal or the metal of the metal compound, and the acid is present in a at least 2: 1 molar excess compared to the ligand. A catalyst system according to claim 20. Wherein the group X ¹ or X ² in the bidentate ligand has a substituent on carbon that is adjacent to or on carbon directly bonded to the Q ² atoms, claim 2 or 17 or 19 The carbonylation method of the ethylenically unsaturated compound described in 1. The carbon of the X ¹ and / or X ² group bonded to the Q ² atom is an aliphatic secondary carbon atom, or the α carbon of the X ¹ and / or X ² group is an aliphatic secondary or tertiary a carbon atom, or carbon bonded to said Q ² atoms, aromatic carbon which forms part of the aromatic ring relative to the Q ² atoms are substituted in the ortho or meta position of the ring The carbonylation method according to any one of claims 2, 17, 19, and 22. The X ¹ or X ² group is prop-2-yl, phen-1-yl, 2-methyl-phen-1-yl, 2-methoxy-phen-1-yl, 2-fluoro-phen-1-yl; 2-trifluoromethyl-phen-1-yl, 2-trimethylsilyl-phen-1-yl, 4-methyl-phen-1-yl, 3-methyl-phen-1-yl, but-2-yl, pent Selected from the group consisting of 2-yl, pent-3-yl, 2-ethyl-phen-1-yl, 2-propyl-phen-1-yl and 2-prop-2′-yl-phen-1-yl 24. The carbonylation method according to any one of claims 2, 17, 19, 22, and 23. 14. The bidentate ligand is selected from the group of claim 13, or the group consisting of phenyl, isopropyl, o-ethylphenyl and o-methoxyphenyl analogs of the aforementioned o-tolyl ligand. Item 25. The carbonylation method according to any one of Items 2, 17, 19, 22 to 24. The X ¹ group represents CH (R ² ) (R ³ ), X ² represents CH (R ⁴ ) (R ⁵ ), X ³ represents CR ⁷ (R ⁸ ) (R ⁹ ), and X ⁴ There represents ^{CR 10 (R 11) (R} 12), represents ^{R 5} is hydrogen the ^{R 2,} alkyl, aryl or H ^{et, R} 7 ~R ¹² represents alkyl, aryl or H et, claim 2, The carbonylation method according to any one of 17, 19, 22 to 25.